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Editor
General Hospital Psychiatry 
Dear editor, 
 
Hereby we would like to submit the manuscript Effectiveness of Suicide Prevention Interventions: A 
Systematic Review and Meta-Analysis by the following authors Emma Hofstra, Chijs van 
Nieuwenhuizen, Marjan Bakker, Dilana Özgül, Iman Elfeddali, Sjakko J. de Jong and Christina M. van 
der Feltz-Cornelis. We hope that you will consider publication in General Hospital Psychiatry. 
The aim of the study was to examine the effectiveness of suicide prevention interventions in terms of 
completed and attempted suicides, and to provide an estimate of their effect size. Furthermore, to 
study whether effectiveness differs across settings in which the intervention is delivered and to 
explore synergism in multilevel interventions. This was done by means of systematic review and 
meta-analysis on controlled studies evaluating suicide prevention interventions versus controls that 
were published between 2011-2017 in PubMed, PsycINFO and Cochrane databases. In this study we 
found a significant effect for suicide prevention interventions on completed suicides and on suicide 
attempts. Also, meta-regression showed a significantly higher effect in relation to the number of 
intervention-levels on its effectiveness. This systematic review and meta-analysis targets important 
gaps in Suicidology as this is  as far as we know - the very first systematic review and meta-analysis 
that provides an estimate of the effect of suicide prevention interventions on completed and 
attempted suicides in controlled studies. Also, it is the first study that explores synergism of 
multilevel interventions in a quantitative manner. 
This research was funded by The Netherlands Organisation for Health Research and Development, 
grant number 537001002. The funder had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The authors of this study had full access to all the data in the 
study and had final responsibility for the integrity of the data, the accuracy of the data analysis and 
the decision to submit for publication and all authors gave their agreement and approval for all 
aspects of the final version of the paper. The authors declare no competing interests.
 
Our manuscript has been professionally proofread by Proof Reading Services (PRS).
In case our manuscript is too long for publication as a whole, we would like to discuss with you the 
possibilities to publish a shortened version. For example, to shorten our manuscript, certain sections 
in the Methods section as well as certain figures might also be published as online supplements. 
We thank you in advance for reviewing our manuscript and for considering it for publication.
This manuscript is not previously published elsewhere or under consideration by another journal. 
 
Kind regards, also on behalf of the co-authors,
 
Emma Hofstra
Ref: GHP_2018_474
Title: Effectiveness of Suicide Prevention Interventions: A Systematic Review and Meta-Analysis 
Journal: General Hospital Psychiatry 
Dear dr. Huffman, 
We have received the review of our manuscript submitted to General Hospital Psychiatry and we 
would like to thank you for inviting us to resubmit it. The reviewers feedback helped us to 
strengthen the manuscript. In this revision letter, we will reply to the reviewers comments and 
outline the changes we have made in our manuscript. We will also submit a revised version of the 
manuscript. 
Reviewer 1
This manuscript presents the findings from a systematic review and meta-analysis of effectiveness 
of interventions aimed to prevent suicidal behavior. Though a relatively large number of recent 
systematic and non-systematic reviews exist, the authors state that their work is the first attempt 
to generate an effect size of studies testing suicide prevention interventions (against a control 
condition). Strengths of the study include the clear and concise writing style, structured and 
systematized literature search, coding process, and reporting of results in line with existing 
standards (e.g., PRISMA), large N across studies (> 250,000 participants total), analyses appropriate 
to the data at hand, clear presentation of results overall (though see minor points below about 
figures), and examination of relevant moderating variables. I believe this is a strong review that will 
contribute nicely to the existing literature - I was surprised to learn that no review to date has 
generated an effect size of suicide prevention interventions in controlled studies - and has the 
potential to be highly cited. I do have a number of suggestions (mostly minor and all addressable, I 
believe) to improve this study's potential to contribute in a meaningful way to the field's knowledge 
about effectiveness of suicide-focused interventions. 
R: We would like to thank the reviewer for his/her compliments as well as for the suggestions 
made. We hope to have met the reviewers comments by the  adjustments made in our revised 
manuscript. 
First, the authors place notable emphasis on their examination of the synergistic effects of 
multilevel interventions, despite the fact that only two studies testing multilevel interventions were 
included. Though this is very briefly noted as a limitation in the Discussion section, I suggest the 
authors significantly temper their discussion of the implications of their findings specific to 
multilevel interventions as there was only one two-level intervention and one three-level 
intervention. This includes tempering the degree to which these findings are emphasized, 
particularly in the Abstract (e.g., Multilevel interventions should be the strategy of choice due to a 
greater effect and a synergistic potential) and Discussion (e.g., multilevel interventions are more 
effective than single level interventions page 25). In this part of the Results section, the authors 
might remind the reader (as it is only mentioned much earlier on in the Methods) that there were 
two multi-level studies total. Though intuitively, multilevel interventions may be more promising for 
reducing suicidal behavior than one-level interventions, interpreting the present data from only two 
multilevel studies to recommend the implementation of multilevel suicide prevention interventions 
above one level may be premature, or at least a statement that should be tempered to reflect the 
small n of these types of studies.  
R: We thank the reviewer for the recommendations regarding the findings specific to multilevel 
interventions. We therefore tempered our findings about multilevel interventions in the 
Abstract. We also reminded the reader that there were two multi-level studies in total in the 
Results section and tempered the implications of our findings in the Discussion. 
We changed the following in the Abstract: 
 Page 1: Further research should focus on multilevel interventions due to their greater 
effects and synergistic potential.
We added the following to the Results section: 
 Page 10, paragraph Study characteristics: A total of 16 studies were included in the 
systematic review. Of these studies, 14 examined a unilevel suicide prevention 
intervention and two a multi-level intervention. Of the two multi-level interventions, one 
study included completed suicides as an outcome measure and one study attempted 
suicides.
We added the following to the Discussion: 
 Page 27, paragraph Strengths and Limitations after A second limitation is that we only 
included two multilevel interventions in the meta-analysis of which one was a two-level 
intervention and one was a three-level intervention. Multilevel interventions should, 
therefore, be the focus of further research, as the current evidence indicates a greater 
effect of multilevel interventions compared to unilevel interventions and synergistic 
potential. 
 Page 29, paragraph Conclusion Moreover, multilevel interventions should be the focus of 
further research due to a greater effect and synergistic potential. 
Second, the authors do not address the possibility that the number of occurrences of suicide 
attempts versus completed suicides (presumably, a much smaller number of observed completed 
suicides) may have impacted their differential findings for attempts on completed suicides (a key 
point in their Discussion). Do the authors have any thoughts about whether this might be another 
possibility (and if so, how this would impact results for effect sizes for suicide attempts versus 
deaths)? 
R: A total of 15 studies were included in the meta-analysis, all together reporting 62 suicides 
and 1006 suicide attempts (participants might have attempted suicide multiple times). We 
added to the Discussion that more studies on completed suicide would foster making more 
precise estimates of the effects. 
We added the following to the Discussion: 
 Page 27, paragraph Strengths and Limitations: Moreover, completed suicides remain a low 
base rate behavior. This resulted in our study in a less precise estimate of the effect, 
compared to suicide attempts. It is desirable for future research that more studies will 
examine the effect of suicide prevention interventions on preventing completed suicide, as 
more studies will enable more precise estimates of the effects. 
It might also be a useful piece of information, if possible, to include the total number of suicide 
deaths and attempts that were observed across the studies included (both to provide more context 
and possibly to further emphasize the value of the current review, in that a very large number of 
patients were included which resulted in a significant, notable number of suicide death 
occurrences, despite this being a very low base rate behavior). 
R: We added the total number of suicide deaths and attempts in the Results section. We also 
included in the Discussion that a very large number of patients were included which resulted in 
a significant, notable number of suicide death occurrences, despite this being a very low base 
rate behaviour. 
We added the following to the Results section: 
 Page 19, paragraph Synthesis of results: A total of 15 studies were included in the meta-
analysis, all together reporting 62 suicides and 1006 suicide attempts (participants might 
have attempted suicide multiple times). 
We added the following to the Discussion: 
 Page 27, paragraph Strengths and Limitations: Moreover, despite completed suicides 
being a very low base rate behavior, we found significant results which is probably due to 
the very large number of patients that were included in our study. 
I also have a number of more minor suggestions/concerns: 
1) Introduction  rationale: Suicide attempts are among the most important known predictors of 
suicide, not necessarily the most important predictor. It would also be helpful to include a citation 
specifically to support this point (e.g., Ribeiro et al 2016 meta-analysis from Psychological Medicine 
on prior suicidal behavior predicting suicide ideation, attempts, and deaths). 
R: We thank the reviewer for the suggestion to include a citation to support the point about 
suicide attempts and we added the citation of Ribeiro et al. 2016. 
We added the following to the Introduction: 
 Page 2: Suicide attempts are among the most important known predictors of completed 
suicide (Ribeiro et al., 2016). 
2) I encourage the authors to consider using the term suicidal thoughts and behaviors rather than 
suicidality as it is more specific/concrete and operationalized. 
R: We have changed the term suicidality into suicidal thoughts and behaviours in the 
Introduction and Discussion, as recommended by the reviewer. 
3) Objectives - #2: To explore if the setting of an intervention moderates efficacy (rather than is 
associated with different effect sizes)  would this be appropriate to say? It is more consistent, I 
believe, with how such aims/analyses are usually described/reported in meta-analyses. 
R: In our opinion, we did explore the association with setting and not a moderation. Moreover, 
other factors might be involved (for example as moderators) as well. Therefore, we would like 
to keep with the original formulation of this objective. 
4) Eligibility criteria: The use of should throughout does not read well in this section, in my 
opinion; I would encourage the authors to use past tense (e.g., eligible studies reported on). 
R: We changed this paragraph to the use of past tense. 
We changed the following to the Methods section:
 Page 4, paragraph Eligibility criteria: Studies were considered eligible if suicides and/or 
suicide attempts were included as an outcome and if a suicide prevention intervention was 
compared with a control group or period.
5) Eligibility criteria: Please define self-harm (SH)  suicidal thoughts and behaviors? Suicidal and 
nonsuicidal thoughts and behaviors (e.g., nonsuicidal self-injury included as well)? 
R: We added a definition of self-harm non-suicidal self-injury) in the manuscript. 
We changed the following to the Methods section:
 Page 4, paragraph Eligibility criteria: The exclusion criterion was the inclusion of self-harm 
(non-suicidal self-injury; SH) in the target group for the intervention. 
6) Study selection/data collection process: Did the authors calculate interrater reliability kappa 
coefficients? Or % of interrater agreement? If not, this might be noted as a limitation. 
R: We thank the reviewer for this suggestion. However, the selection procedure in our study was 
not set up in a manner that calculating an interrater reliability kappa coefficient would be relevant. 
Therefore, we did not calculate interrater reliability kappa coefficients. Since it was not relevant 
for the procedure at hand, we do not consider this as a limitation of the study. For further 
clarification, we have described our procedure of risk of bias assessment in more detail. 
7) Discussion: I am curious about the research to support the statements that individuals who 
complete suicide have fewer psychiatric problems than those who attempt suicide  could this be an 
artefact of those who complete suicide being less likely to see mental health practitioners? How 
strong are the studies to support this comment (given that it seems somewhat counterintuitive)? 
R: We agree with the reviewer that more research is needed to whether individuals that 
complete versus attempt suicide differ in how many psychiatric disorders they have. Therefore, 
we changed this statement in the Discussion. 
We changed the following to the Discussion:
 Page 25: More research is needed to whether individuals that complete versus attempt 
suicide differ with regards the presence of psychiatric disorders.
8) PRISMA figure: The Records excluded (n=1) box (presumably the Pearson et al. 2017 study) 
should include a brief mention of why that study was excluded (as described in more detail 
elsewhere in the paper). 
R: We added a brief mention in the PRISMA figure of why the study of Person et al. 2017 was 
excluded. 
We added the following in Figure 1:
 Could not be pooled due to different outcomes (n = 1)
9) The tables corresponding to the forest plots exported directly from CMA are somewhat blurry (at 
least in my version of the manuscript) and a bit hard to read. I would encourage the authors to 
consider putting the tabular information into a separate table (i.e., in word or excel), not export 
directly from CMA.
R: We created new forest plots -including the tables- in excel, to avoid blurriness. 
Reviewer 2
Please clarify what the authors are referring to when they state until now an estimate of the 
effect size has not been provided. Was the Odds Ratios in Zalsman et al. in 2016 not an effect size? 
R: We would first like to thank the reviewer for the very attentive reading of our manuscript. 
We hope that the adjustments we made in the manuscript will meet the comments of the 
reviewer. With regards to the comment about an estimate of the effect size: the Odds Ratio in 
Zalsman et al. 2016 is indeed an effect size. However, it is based on one intervention in a 
school setting and a comparative estimate for the effect of different types of interventions has 
therefore not yet been provided. Therefore, we changed our statement in the Introduction and 
Discussion. 
We changed the following in the Introduction: 
 Page 2: Despite growing evidence for the effectiveness of several suicide prevention 
strategies, until now a comparative estimate for the effect of different types of 
interventions has not yet been provided.
We changed the following in the Discussion: 
 Page 24: The meta-analysis, for the first time, provides a comparative estimate for the 
effect of different types of suicide prevention interventions, based on 15 controlled 
studies, with 29,071 participants in various settings.
Why limit studies to such a short window 2011-2017? If an effect size has not been reported then 
why not pool all available data? The systematic review of van der Feltz-Cornelis does not appear to 
have a reference where it is mentioned, pg. 5. 
R: Our study further elaborates on the systematic review of van der Feltz-Cornelis, which was 
published in 2011. We extended our search from January 2011 through December 2017. For 
clarification of the reader, we added a reference on page 5 where we mentioned the time 
window of our study. 
The outcomes are very poorly defined. Please elaborate and provide detailed information, e.g. was 
family report of an attempt eligible? This is particularly necessary to clarify as outcomes appear to 
be analysed as SMD and converted to Cohens d, rather than as binary outcomes which one would 
presume a suicide attempt or completion is. 
R: We would like to thank the reviewer for pinpointing this aspect. We provided further 
information on the outcomes in the Methods section. Family records were considered as non-
eligible. We chose to convert the outcomes to Cohens d to be able to perform a meta 
regression, which would not be possible if we analysed Odds Ratios. Moreover, by analysing 
Cohens d we will be able to compare our study with other mental health care review studies, 
which mostly report effect sizes in Cohens d as well. 
We added the following in the Methods section: 
 Page 7, paragraph Data items: Outcomes were completed or attempted suicides in 
quantitative measures, as defined by healthcare professionals (hospital records, 
questionnaires, or interview) or coroners records, as can be seen in Table 1 and 2. 
For the effect sizes that are only mentioned in text and not provided as a CMA figure, it would be 
easier to follow if some information as provided in a table or combined forest plot (done with 
excel), showing the n studies and heterogeneity statistics as well as effect sizes. 
R: We thank the reviewer for this suggestion. We created new forest plots in excel, and 
provided relevant information. 
Minor points 
Possibly either the aim or objectives could be omitted at the end of the intro to avoid repetition. 
R: We agree with the reviewer that the aim and objectives created repetition. Therefore, we 
moved the aim from the Introduction to the start of the Discussion, and changed the sentence to 
past tense. 
We added the following to the Discussion: 
 Page 24: The aim of this review was to evaluate the effectiveness of suicide prevention 
interventions in different settings, to compare their relative effectiveness by providing an 
estimate of their effect size, and to explore possible synergism of multilevel interventions 
in a meta-analysis.
Presumably peer reviewers are blinded to the PROSPERO ID?
R: As the review process of General Hospital Psychiatry is blinded, we were asked to submit a 
blinded manuscript (without author details). Identifying information is provided in the PROSPERO 
register, and hence we blinded the PROSPERO ID in our manuscript.
The reason for exclusion of Pearson et al. (2017) should be listed in the Flow chart. 
R: We added a brief mention in the PRISMA figure of why the study of Person et al. 2017 was 
excluded. 
We added the following in Figure 1:
 Could not be pooled due to different outcomes (n = 1)
Suggest using to when reporting negative confidence intervals in text. 
R: We thank the reviewer for this suggestion. For the clarity for the reader, however, we would 
like to maintain a uniform notation in reporting positive and negative confidence intervals. Hence, 
we would like to maintain the use of semicolons. 
The conclusion To conclude. Is not the last para, please move accordingly. 
R: We added a Conclusion paragraph in the Discussion, and we moved the conclusion of our study 
to this paragraph. Therefore, we removed To conclude of the sentence. 
We added a Conclusion paragraph in the Discussion
Running title: EFFECTIVENESS SUICIDE PREVENTION INTERVENTIONS
Effectiveness of Suicide Prevention Interventions: A Systematic 
Review and Meta-Analysis 
Article data: figures: 6; tables: 3; appendices: 2; word length article text: 4916; word length 
abstract: 224
1Abstract
Objective: This study provides an estimate of the effect size of suicide prevention 
interventions and evaluates the possible synergistic effects of multilevel interventions. 
Method: A systematic review and meta-analysis were conducted of controlled studies 
evaluating suicide prevention interventions versus control published between 20112017 in 
PubMed, PsycINFO, and Cochrane databases. Data extraction and risk of bias assessment 
according to ROBINS criteria were performed by independent assessors. Cohens delta was 
calculated by a random meta-analysis on completed and attempted suicides as outcomes. 
Meta-regression explored a possible synergistic effect in multilevel interventions. 
PROSPERO ID number: X. Results: The search yielded 16 controlled studies with a total of 
252,932 participants. The meta-analysis was performed in 15 studies with 29,071 participants. 
A significant effect was found for suicide prevention interventions on completed suicides (d=-
0.535, 95% CI -0.898; -0.171, p=.004) and on suicide attempts (d=-0.449, 95% CI -0.618; -
0.280, p<.001). Regarding the synergistic effect of multilevel interventions, meta-regression 
showed a significantly higher effect related to the number of levels of the intervention 
(p=.032). Conclusions: Suicide prevention interventions are effective in preventing 
completed and attempted suicides and should be widely implemented. Further research should 
focus on multilevel interventions due to their greater effects and synergistic potential. 
Multilevel interventions should be the strategy of choice due to a greater effect and a 
synergistic potential. Further research is also needed into risk appraisal for completed versus 
attempted suicide, as the preferred intervention strategy differs with regard to both outcomes. 
Keywords: suicide prevention, intervention, effectiveness, synergism, systematic review, 
meta-analysis, controlled studies
2Introduction 
RATIONALE
Suicide is a worldwide major public health problem, with 800,000 suicides annually.1 Suicide 
attempts are among , the most important known predictors of completed suicides, and occur 
even more often.1,2 Since the 2013 commitment of the World Health Organisation Member 
States to work towards suicide prevention,3 ample national strategies and suicide prevention 
interventions have been developed and overviews of them provided in systematic reviews.4-17 
The effectiveness of suicide prevention interventions in reducing suicide rates is found in 
certain settings, but not (yet) in others.4,8,11,12 In 2005, Mann et al. performed a systematic 
review pertaining to suicide prevention strategies in general;18 this review was updated by 
Zalsman et al. in 2016.4 Despite growing evidence for the effectiveness of several suicide 
prevention strategies, until now a comparative estimate for the effect of different types of 
interventions has not yet been provided. Despite growing evidence for the effectiveness of 
several suicide prevention strategies, until now an estimate of the effect size has not been 
provided. Also, it remains unclear which strategy is the most effective and if the setting of 
intervention is relevant to the effect. 
It has been argued that effective action towards reducing suicide would need combined 
interventions by different providers in multiple domains3,4,18  so-called multilevel 
interventions.19,20 For example, at the community level, this could be accomplished by: (1) 
providing gatekeepers such as teachers and with priests training others to aid recognition of 
persons potentially at risk; (2) combining it with a publicity campaign21,22 and with (3) 
instructions to the press on how to publish information on suicides. In addition, on the 
primary care level, general practitioners could be trained on how to address suicidality 
suicidal thoughts and behaviour in patients. Indications of the effectivity of multilevel 
interventions were found in non-controlled studies;20,23,24 however, this effect was not 
3replicated in one of the very few published randomised controlled trials examining the 
effectiveness of a multilevel intervention in preventing suicidal behaviour.22 
Multilevel interventions have been suggested as having synergistic potential,19 
meaning that the effect of the combined parts of the intervention might create a stronger effect 
than the sum of the individual effects of the interventions. Hegerl et al. (2006) observed, 
during the implementation of a four-level community-based suicide prevention intervention, 
that general practitioners were more motivated to participate in the training sessions because 
the ongoing public campaign aimed at destigmatisation prompted their patients to present 
themselves with possible depressive symptoms and suicidal ideation.24 Synergistic 
interactions between intervention levels were also suggested by a qualitative study on 
multilevel suicide prevention interventions in four European countries.25 However, thus an 
estimate of a possible synergistic effect has not been provided.19,20 The aim of this review is to 
evaluate the effectiveness of suicide prevention interventions in different settings, to compare 
their relative effectiveness by providing an estimate of their effect size and to explore possible 
synergism of multilevel interventions in a meta-analysis.
OBJECTIVES 
This study has three objectives: 
1. To establish an estimate of the effect of suicide prevention interventions for completed 
suicides and suicide attempts;
2. To explore if the setting of intervention is associated with different effect sizes;
3. To explore if multilevel interventions have synergistic effects.
4Methods
PROTOCOL AND REGISTRATION
The study protocol is registered in PROSPERO, the international prospective register of 
systematic reviews of the University of York (www.crd.york.ac.uk/prospero/) and is 
accessible under ID number X. The Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) statement for transparent reporting was followed.26 The PRISMA 
checklist is included in Appendix 1.
ELIGIBILITY CRITERIA 
Studies were considered eligible if suicides and/or suicide attempts were included as an 
outcome and if a suicide prevention intervention was compared with a control group or 
period. Eligible studies should report on suicides and/or on suicide attempts as an outcome. 
They should compare a suicide prevention intervention with a control group or period. Studies 
were included when randomisation was performed between patients or between practice 
settings,27 but could also be Controlled Cohort Studies (CCS), Controlled Before After studies 
(CBAs), Controlled Interrupted Time Series (CITS), or Interrupted Time Series (ITS) studies. 
Principal outcomes were suicide attempts and completed suicides and had to be defined in 
quantitative measures in order to make meta-analysis possible. The exclusion criterion was 
the inclusion of self-harm (non-suicidal self-injury; SH) in the target group for the 
intervention. The exclusion criterion was the inclusion of self-harm (SH) in the target group 
for the intervention. 
INFORMATION SOURCES
Potentially eligible studies were identified by searching the databases PubMed, PsycINFO 
and the total database of the Cochrane Library (including Cochrane Database of Systematic 
5Reviews, Database of Abstracts of Reviews of Effect, Cochrane Central Register of 
Controlled Trials, Health Technology Assessment Database, and NHS Economic Evaluation 
Database). As this study further elaborates on the systematic review of van der Feltz-Cornelis, 
which was published in 2011, our search extended from January 2011 through December 
2017.19 The reference lists of reviews were checked for missed studies. Personal files of the 
workgroup members were checked for relevant publications, and experts from the section 
suicidology and suicide prevention of the European Psychiatric Association 
(https://suicidologysection.org) and from the European Alliance Against Depression (EAAD) 
(www.eaad.net) were consulted about relevant publications in order to identify additional 
studies not found by our search strategy.
SEARCH
A search was performed of systematic reviews of randomised or controlled studies in the field 
of suicide prevention interventions with MeSH terms and free text terms for suicide 
prevention AND intervention AND systematic review. A second search was run with 
suicide prevention AND intervention AND clinical trial. Randomised or controlled 
studies in the field of suicide prevention interventions were included. Only studies with a 
primary focus on suicide reduction were selected. The search strategy for PubMed is shown in 
Appendix 2. It was adapted for the other databases. We did not use language restrictions to 
minimise Tower of Babel Bias.28
STUDY SELECTION
After identifying studies from database searching and additional sources, duplicate records 
were removed. The titles and abstracts of the records were assessed to determine eligibility in 
a first screening and the full-text articles were assessed for eligibility in a second screening. 
6The screenings were performed in duplicate (X and X). If the two independent assessors had 
disagreements in coding, a third assessor (X) was consulted to make the final decision. 
DATA COLLECTION PROCESS
An overview of participants, interventions, comparisons, outcomes and study design (PICOS) 
is shown in Tables 1 and 2. The extraction of data was performed independently by two 
researchers (X and X). In the case of non-consensus, a third assessor (X) was consulted to make 
the final decision. 
DATA ITEMS
Two tables are provided, one for studies evaluating completed suicides and one for suicide 
attempts. Interventions are categorised as one level or multilevel, and the number of levels is 
provided by the third researcher of this study (X). The data items of each study are described 
below.
Type of study design
Included studies could be Randomised Controlled Trials, Cluster Randomised Controlled 
Trials, Controlled Cohort studies (CCs), Controlled Before After studies (CBAs), Controlled 
Interrupted Time Series (CITS) or Interrupted Time Series (ITS) studies.
Details of the intervention
Suicide prevention strategies may include community approaches, psychotherapeutic 
interventions, pharmacotherapeutic and multilevel interventions, with the prerequisite for 
inclusion that the intervention is sufficiently described to classify it as a suicide prevention 
intervention aimed at reducing attempted or completed suicides. The number of intervention 
7levels was taken into account in the analysis, as was the setting, which could be the 
community, emergency room, outpatient specialty mental health setting or a psychiatric ward 
in a general hospital.
Patient groups
Targeted populations could be suicidal persons in the various settings mentioned above; 
psychiatric patients, children and adolescents, older people, certain professional groups such 
as veterans, as well as ethnic minorities. There was no restriction on the kind of mental 
disorders.
Outcome definitions
Outcomes were completed or attempted suicides in quantitative measures, as defined by 
healthcare professionals (hospital records, questionnaires, or interview) or coroners records, 
as can be seen in Table 1 and 2. Outcomes were completed or attempted suicides in 
quantitative measures. Measurement instrument and follow-up time were recorded. 
Level of evidence
Level of evidence was defined according to the criteria of the Oxford Centre of Evidence-
Based Medicine.29
RISK OF BIAS IN INDIVIDUAL STUDIES
The quality of each study was determined by assessing the risk of bias in both the study and 
outcome level. Risk of bias (ROB) assessment was performed by two assessors (X, X) who 
discussed beforehand the required approach based upon the Cochrane Risk Of Bias in Non-
randomised Studies  of Interventions (ROBINS-I)30 and double-scored one of the articles. As 
8no particularities in assessment were observed, all the other studies were individually assessed 
by the two assessors. In ROB appraisal, as confounding factors, co-therapies such as 
pharmacotherapy or psychotherapy on top of the suicide prevention intervention were 
considered, as well as including both suicidal persons and persons performing self-harm in the 
study. In the case of RCTs, the most important Cochrane quality criterion, namely 
randomisation,31,32 was explicitly mentioned. The results of this risk-of-bias assessment are 
shown in Table 3. Furthermore, a meta-regression explored if an association existed between 
the risk of bias of the studies and the effect size of the interventions.
SUMMARY MEASURES
We used the rates of completed or attempted suicides in intervention and control conditions 
for pooling. We calculated the effect sizes for each study using Comprehensive Meta-analysis 
version 2.33 We chose to take the following outcome measures into account for the analysis:
1) As a first step, the combined effect on completed and attempted suicides was analysed and 
labeled suicidal behaviour. 
2) Subsequently, separate analyses on those two outcomes were performed, with larger 
negative effect sizes being an improvement compared to smaller negative effect sizes, and 
effect sizes above zero a deterioration.
The effects were presented in terms of standardised effect sizes (Cohen's d). These effect sizes 
indicate by how many standard deviations the intervention group performed better than the 
control group. The effect size d is calculated by subtracting the average score of the control 
group (Mc) from the average score of the experimental group (Me) and dividing the raw 
difference score by the pooled standard deviation of the experimental and control group.34 An 
effect size of 0.5 indicates that the mean of the experimental group is half a standard deviation 
larger than the mean of the control group. In general, one considers an effect size of 0.561.2 
9a large clinical effect, an effect size of 0.330.55 moderate, and an effect size of 00.32 as 
small.35,36
SYNTHESIS OF RESULTS
We performed a random-effects meta-analysis to examine the effectiveness of interventions 
on suicide prevention.37 Between-study heterogeneity was assessed using the Q-statistic,38 
which reflects the observed dispersion. In order to quantify this dispersion, the I2 statistic was 
used, which describes the percentage of total variation across studies that is the result of 
heterogeneity rather than of chance. All statistical pooling was conducted using 
Comprehensive Meta-Analysis, version 2.33
RISK OF BIAS ACROSS STUDIES
Publication bias was examined by constructing a Begg funnel plot39 and running a Stern & 
Egger test.40 
ADDITIONAL PRE-ENVISIONED MODERATOR ANALYSES
The setting of the intervention was explored as a moderator. Also, suicide prevention 
interventions were labelled as multilevel if they contained elements that were performed in 
different settings and by different providers.19 Effect sizes of multilevel interventions were 
compared with effect sizes of non-multilevel interventions. In the case of multilevel 
interventions, an estimate of the effect was made to explore the potential of synergism by 
meta-regression. In the case of synergism, an exponential effect was expected. 
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Results 
STUDY SELECTION
The database search identified 442 records. In addition, 172 records were identified by 
consulting suicide prevention experts (19 records) and by identifying studies from literature 
reviews about suicide prevention interventions (153 records). After removal of duplicates, 447 
records remained. After screening the records on title and abstract, 389 records were excluded 
and 58 articles were assessed for eligibility based on the full text (46 through database 
searching and 12 through additional sources). Finally, 16 studies were included in the 
systematic review. The study of Pearson et al. (2017) could not be pooled due to different 
outcomes, namely person-years. Hence, 15 studies were included in the meta-analysis, as is 
shown in Figure 1. 
[ Insert Figure 1 about here ]
Figure 1. PRISMA flow diagram (2009) of the different phases of the systematic review
STUDY CHARACTERISTICS 
An overview of the study and characteristics with regards to participants, interventions, 
comparisons, outcomes and study design (PICOS) for studies evaluating completed suicide 
and suicide attempts are presented in Tables 1 and 2. A total of 16 studies were included in 
the systematic review. Of these studies, 14 examined a unilevel suicide prevention 
intervention and two a multi-level intervention. Of the two multi-level interventions, one 
study included completed suicides as an outcome measure and one study attempted suicides.
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Table 1. Overview of participants, interventions, comparisons, outcomes, and study design (PICOS) for studies evaluating completed suicide
Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Unilevel N=234,589 d=-0.334 (95% CI -0.804; 
0.136, p=.163)
Vijayakumar et 
al., 201141
RCT (1b) - 622 participants in one 
general hospital (Admitted 
GHP)
- India
Suicide attempters 
>12 years, admitted 
in a general hospital
Brief intervention and contact 
(BIC) (n=302) versus TAU 
(n=320)
- Study 
questionnaire
- 18 months 
Significant less suicides in BIC 
compared to control group (d=
-1.193, CI -2.336; -0.051, 
p=.041).
Hvid et al., 
201142 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark
Suicide attempters 
arriving at the 
hospital ED and 
clinical departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital 
records
- 12 months
No significant difference 
between OPAC and control 
group (d=0.348, CI -0.989; 
1.685, p=.610).
Wasserman et 
al., 201543
Cluster-
RCT (1b)
- 8,182 participants in 168 
schools (Community level)
- European Union (EU) 
countries
Adolescent pupils 
recruited from EU 
schools
Question, Persuade and Refer 
(n=1,978) and Youth Aware 
of Mental Health Programme 
(n=1,987) and screening by 
professionals (n=1,961) versus 
exposure to educational 
posters in the classroom 
(n=2,256)
- Paykel 
Hierarchical 
Suicidal 
Ladder44
- 12 months
No significant difference 
between intervention groups 
and a control group (no 
participants completed suicide 
during the study period).c
Rudd et al., 
201545
RCT (1b) - 108 participants in one 
Military Hospital 
(Outpatient SMHI)
- USA
Active-duty Army 
soldiers with 
suicide attempt or 
ideation 
Brief cognitive-behavioural 
therapy (BCBT) (n=54) 
versus TAU (n=54)
- Suicide 
Attempt Self-
Injury 
Interview46
- 24 months
No significant difference 
between BCBT and control 
group (d=0.000, CI -1.538; 
1.538, p=1.000).
Amadéo et al., 
201547
RCT (1b) - 190 participants in one 
hospital psychiatric 
emergency department 
(Admitted GHP)
- French Polynesia
Patients who sought 
help due to non-
fatal suicidal 
behaviour 
Brief Intervention and Contact 
(BIC) (n=90) versus TAU 
(n=100) 
- Coroners 
records
- 18 months 
No significant difference 
between BIC and control group 
(d=-0.841, CI -2.522; 0.841, 
p=.327).
Lahoz et al., 
201648 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
Suicide attempters 
arriving at the 
Outreach, Problem solving, 
Adherence, Continuity 
- Hospital 
records
- 60 months
No significant difference 
between OPAC and control 
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
- Denmark hospital ED and 
clinical departments
(OPAC) program (n=65) 
versus TAU (n=60)
group (d=-0.043, CI -1.140; 
1.054, p=.939).
Miller et al., 
201749
PP (2c) - 1,376 participants in 8 
hospital EDs (ED)
- USA
Adults with recent 
suicide attempt or 
ideation presented 
to hospital ED 
Emergency Department Safety 
Assessment and Follow-up 
Evaluation (ED-SAFE) + 
Screening (n=502) or 
Screening alone (n=377) 
versus TAU (n=497)
- Columbia 
Suicide Severity 
Rating Scale50 + 
medical records
- 12 months
No significant difference 
between ED-SAFE and control 
group (d=-0.289, CI -1.082; 
0.503, p=.474).
Pearson et al., 
201751 b
Cluster-
RCT (1b)
- 223,861 participants in 
the community 
(Community level)
- Sri Lanka 
People aged 14 
years or older in 
households living in 
rural villages
Distribution and promotion of 
household lockable pesticide 
storage (n=114,168) versus 
usual practice (n=109,693)
- Hospital, 
community and 
coroner data
- 36 months
No significant difference 
between the intervention group 
and the control group.c
Multilevel
Three-level N=14,309 d=-0.832 (95% CI -1.406; 
-0.259, p=.004)
Mishara et al., 
201252
PP (2c) - 14,309 participants of all 
Montreal police and rest of 
Quebec police (QP) 
(Community level)
- Canada
Montreal police 
(MP) officers 
Together for Life in Montreal 
police (n=4,178) versus no 
intervention in rest of Quebec 
police (n=10,131)
- Quebec 
Coroners 
Office on all 
police suicides
- 144 months
Significant fewer suicides in 
intervention compared to 
control group (d=-0.832, CI 
-1.406; -0.259, p=.004).
Note: a The study of Lahoz et al., 2016 is a 5-year followup of the study of Hvid et al., 2011. 
b The study of Pearson et al., 2017 reported in person-years and was not included in the meta-analysis. 
c The study of Wasserman et al., 2015 and Pearson et al., 2017 were not included in the meta-analysis to completed suicides; effect size is therefore not provided in the table.
Abbreviations: ED = emergency department. GHP = psychiatric ward in general hospital. OPAC = suicide prevention intervention named Outreach, Problem-solving, Adherence, Continuity 
programme. PS = suicide prevention intervention named Screening by professionals. PP = pre-post design. QPR = suicide prevention intervention named Question, persuade and refer. RCT = 
randomised controlled trial. SMHI = specialty mental health institution. TAU = treatment as usual. YAM = suicide prevention intervention named Youth aware of mental health programme. 
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Table 2. Overview of participants, interventions, comparisons, outcomes, and study design (PICOS) for studies evaluating attempted suicide
Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Unilevel N=237,387 d=-0.443 (95% CI -0.632 
;0.254, p<.001)
Hassanian-
Moghaddam et 
al., 201153
RCT (1b) - 2,113 participants in one 
poison Hospital ED (ED)
- Iran 
Suicide attempters 
by self-poisoning 
>12 years
Postcard intervention 
(n=1,043) versus TAU 
(n=1,070)
- Study 
questionnaire + 
hospital records
- 12 months
Significant less suicide attempts 
in intervention compared to 
control group (d=-0.306, CI 
-0.544; -0.069, p=.012).
Vijayakumar et 
al., 201141
RCT (1b) - 622 participants in one 
general hospital (Admitted 
GHP)
- India
Suicide attempters 
>12 years, 
admitted in a 
general hospital
Brief intervention and contact 
(BIC) (n=302) versus TAU 
(n=320)
- Study 
questionnaire
- 18 months 
No significant difference 
between BIC and control group 
(d=-0.399, CI -0.871; 0.073, 
p=.097).
Hvid et al., 
201142a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark 
Suicide attempters 
arriving at the 
hospital ED and 
clinical 
departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital records
- 12 months
Significant less suicide attempts 
in OPAC compared to control 
group (d=-0.784, CI -1.434; 
-0.133, p=.018).
Cebrià et al., 
201354
CCS (3b) - 514 participants in two 
hospital emergency 
departments (ED)
- Spain
Suicide attempters 
discharged from 
ED
Systematic one-year telephone 
follow-up (n=296) versus 
TAU (n=218)
- Medical records
- 12 months 
Significant less suicide attempts 
in intervention compared to 
control group (d=-0.587, CI 
-0.935; -0.239, p=.001).
Mousavi et al., 
201455
RCT (1b) - 139 participants in one 
hospital ED (ED)
- Iran 
Suicide attempters 
>15 years, 
admitted to 
hospital ED
Brief interventional contact 
(BIC) (n=69) versus TAU 
(n=70)
- Study 
questionnaire
- 6 months
No significant difference 
between BIC and control group 
(d=-0.781, CI -2.003; 0.442, 
p=.211).
Wasserman et 
al., 201543
Cluster-
RCT (1b)
- 8,182 participants in 168 
schools (Community level)
- European Union (EU) 
countries
Adolescent pupils 
recruited from EU 
schools
Question, Persuade and Refer 
(n=1,978) and Youth Aware 
of Mental Health Program 
(n=1,987) and screening by 
professionals (n=1,961) versus 
exposure to educational 
posters in the class room 
(n=2,256)
- Paykel 
Hierarchical 
Suicidal Ladder44
- 12 months
Significant less suicide attempts 
in YAM compared to control 
group (d=-0.424, CI -0.768; 
-0.079, p=.016). No significant 
difference between PS and 
control group (d=-0.218, CI
-0.524; 0.088, p=.163). No 
significant difference between 
QPR and control group (d=
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
-0.170, CI -0.467; 0.128, 
p=.264).
Rudd et al., 
201545
RCT (1b) - 108 participants in one 
military Hospital 
(Outpatient SMHI)
- USA
Active-duty Army 
soldiers with 
suicide attempt or 
ideation 
Brief cognitive-behavioural 
therapy (BCBT) (n=54) 
versus TAU (n=54)
- Suicide Attempt 
Self-Injury 
Interview46
- 24 months
Significant less suicide attempts 
in BCBT compared to control 
group (d=-0.535, CI -1.033; 
-0.037, p=.035).
Gysin-Maillart 
et al., 201656
RCT (1b) - 103 participants in one 
psychiatric department 
General Hospital 
(Outpatient SMHI)
- Switzerland
Suicide attempters 
admitted to ED
Attempted Suicide Short 
Intervention Programme 
(ASSIP) (n=56) versus TAU 
(n=47)
- Questionnaire
- 24 months
Significant less suicide attempts 
in ASSIP compared to control 
group (d=-1.746, CI -2.333; 
-1.159, p<.001).
Lahoz et al., 
201648 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark
Suicide attempters 
arriving at the 
hospital ED and 
clinical 
departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital records
- 60 months
No significant difference 
between OPAC and control 
group (d=-0.146, CI -0.585; 
0.294, p=.516).
Goodman et al., 
201657
RCT (1b) - 47 participants in one 
veterans outpatient 
medical center (Outpatient 
SMHI)
- USA
High risk suicidal 
veterans, aged 18-
55 years
Dialectical Behavioral 
Therapy (DBT) (n=27) versus 
TAU (n=20)
- Columbia
Suicide Severity 
Rating Scale50
- 12 months
No significant difference 
between DBT and control 
group (d=-0.322, CI -1.146; 
0.503, p=.444).
Bryan et al., 
201758
RCT (1b) - 72 participants in one 
military medical clinic 
(Admitted GHP)
- USA
Active duty U.S. 
Army Soldiers, 
aged 18+ with 
suicidal ideation 
or attempt 
Crisis Response Planning 
standard (CRP-s) (n=23) and 
Crisis Response Planning 
enhanced (CRP-e) (n=24) 
versus Contract for Safety 
(CfS) (n=25)
- Suicide Attempt 
Self-Injury 
Interview46
- 6 months 
No significant difference 
between CRP and control group 
(d=-0.740, CI -1.567; 0.088, 
p=.080).
Miller et al., 
201749
PP (2c) - 1,376 participants in 8 
hospital EDs (ED)
- USA
Adults with recent 
suicide attempt or 
ideation presented 
to hospital ED 
Emergency Department Safety 
Assessment and Follow-up 
Evaluation (ED-SAFE) + 
Screening (n=502) or 
Screening alone (n=377) 
versus TAU (n=497)
- Columbia 
Suicide Severity 
Rating Scale50 + 
medical records
- 12 months
No significant difference 
between ED-SAFE and control 
group (d=-0.156, CI -0.326; 
0.014, p=.072).
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Pearson et al., 
201751 b
Cluster-
RCT (1b)
- 223,861 participants in 
the community 
(Community level)
- Sri Lanka
People aged 14 
years or older in 
households living 
in rural villages
Distribution and promotion of 
household lockable pesticide 
storage (n=114,168) versus 
usual practice (n=109,693)
- Hospital, 
community and 
coroner data
- 36 months
No significant difference 
between the intervention group 
and the control group.c
Multilevel
Two-level N=1,046 d=-0.622 (95% CI -1.034;
-0.210, p=.003)
Schilling et al., 
201659 
Cluster-
RCT (1b)
- 1,046 participants in 16 
technical high school 
(Community level)
- USA
Ninth grade 
students in 
technical high 
school 
Signs of Suicide (SOS) 
(n=650) versus wait list 
control group (n=396)
- Single-item 
measure from the 
Youth Risk 
Behavior Survey60
- 3 months
Significant less suicide attempts 
in SOS compared to control 
group (d=-0.622, CI -1.034; 
-0.210, p<.003).
Note: a The study of Lahoz et al., 2016 is a 5-year follow-up of the study of Hvid et al., 2011. 
b The study of Pearson et al., 2017 reported in person-years and was not included in the meta-analysis. 
c The study of Pearson et al., 2017 was not included in the meta-analysis to suicide attempts; effect size is therefore not provided in the table.
Abbreviations: CCS = case-control study. ED = emergency department. GHP = psychiatric ward in general hospital. OPAC = suicide prevention intervention named Outreach, Problem solving, 
Adherence, Continuity programme. PS = suicide prevention intervention named Screening by professionals. PP = pre-post design. QPR = suicide prevention intervention named Question, 
persuade and refer. RCT = randomised controlled trial. SMHI = specialty mental health institution. TAU = treatment as usual. YAM = suicide prevention intervention named Youth aware of 
mental health programme.
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RISK OF BIAS WITHIN STUDIES
The quality ratings of the studies are shown in Table 3. Thirteen studies were randomised 
studies (RCTs). Two out of 16 studies (12.50%) had a low overall risk of bias, meaning that 
these studies were comparable to a well-performed randomised trial.61 Nine studies had a 
moderate overall risk of bias (56.25%), meaning that these studies provided sound evidence 
for a non-randomised study but cannot be considered comparable to a well-performed 
randomized trial.61 Five studies (31.25%) had a serious overall risk of bias, meaning that 
these studies had some important problems.61 No studies showed a critical risk of bias. All 
studies were considered of sound quality according to the guidelines of the Oxford Centre of 
Evidence-Based Medicine.29 Hence, all studies were used in the analyses. 
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Table 3. Risk of bias within studies 
Study Random-
isation
Confound-
ing
Selection of 
participants
Classifi-
cation of 
intervention
Deviation 
intended    
intervention
Missing 
data
Measure-
ment of 
outcomes
Selection 
reported 
result
Overall 
bias
Comments
Amadéo et 
al., 201547 
Yes Low Low Low Low Moderate Low Low Moderate Two-tailed test in spite of the apparently expected 
direction of the effect; small sample size; missing 
data.
Bryan et al., 
201758 
Yes Low Moderate Low Moderate Low Low Low Moderate Small sample size (N=97) and delay in 
interventions due to recruitment 
suspension (recruitment goal was N=360). 
Cebrià et al., 
201354 
No Serious Low Low Low Low Moderate Low Serious No information about SH; outcome measure could 
have been influenced by knowledge of the 
intervention received in the experimental setting 
(change in 2008).
Goodman et 
al., 201657 
Yes Moderate Low Low Low Serious Low Low Serious A high number of drop-out, no ITT/NTT; no 
information about SH.
Gysin-
Maillart et al., 
201656
Yes Low Low Low Low Moderate Low Low Moderate Missing data due to drop-out.
Hassanian-
Moghaddam 
et al., 201153 
Yes Low Low Low Low Low Low Low Low Good quality study. 
Hvid et al., 
201142 
Yes Low Low Moderate Low Low Moderate Low Moderate Single-blind study; one catchment area so people 
might, by chance, know each other or meet in the 
hospital.
Lahoz et al., 
201648 
Yes Low Low Low Low Low Low Low Low Completed and attempted suicide was taken 
together as an outcome.
Miller et al., 
201749 
No Serious Low Low Low Low Low Moderate Serious Time might have influenced outcomes, time and 
site (probably) not in final analysis, no information 
about validity and reliability measures; possible 
selection of analysis/covariates.
Mishara et 
al., 201252 
No Moderate Serious Moderate Low Moderate Low Low Serious Various interventions in different fields, therefore 
no clearly defined intervention; no outcome data at 
follow-up; missing data.
Mousavi et 
al., 201455 
Yes Low Low Moderate Low Low Moderate Low Moderate Randomisation after the first interview; 
randomisation, missing data and assessment of 
information are not clearly described.
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Pearson et al., 
201751 
Yes Moderate Low Low Low Low Low Low Moderate Cluster RCT, although corrected in analyses.
Rudd et al., 
201545 
Yes Low Low Low Low Low Low Moderate Moderate Multiple analyses of the intervention-outcome 
relationship not registered; no significant effect on 
Fisher exact (two-tailed); analysis selection is 
possible.
Schilling et 
al., 201659
Yes Moderate Low Low Low Serious Moderate Low Serious Cluster RCT; only significant demographics were 
included; proportions of participants not given, but 
probably contrary; more missing items at pre-test; 
self-assessment.
Vijayakumar 
et al., 201141 
Yes Low Low Low Low Moderate Moderate Low Moderate Some 5-10% lost to follow-up; more missing items 
in TAU-group which decreases the effect; potential 
bias in the measurement of outcomes.
Wasserman et 
al., 201543
Yes Low Low Low Low Moderate Moderate Low Moderate Cluster RCT; missing data; self-assessment.
Note: Confounding = pre-intervention bias due to confounding. Selection of participants = pre-intervention bias in the selection of participants into the study. Classification of intervention = at-
intervention bias in classification of interventions. Deviation intended intervention = post-intervention bias due to deviations from intended interventions. Missing data = Post-intervention bias 
due to missing data. Measurement of outcomes = Post-intervention bias in measurement of outcomes. Selection reported result = Post-intervention bias in the selection of the reported result.61
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RESULTS OF INDIVIDUAL STUDIES
A total of 16 studies with 252,932 participants were selected for the systematic review. All 
studies were published in the time period of 20112017. Thirteen studies were (cluster) 
randomised controlled trials (81.3%),41-43,45,47,48,51,53,55-59 two studies were a pre-post design 
study (12.5%),49,52 and one study was a case-controlled design (6.3%).54 Fourteen 
interventions evaluated unilevel interventions (87.5%),41-43,45,47-49,51,53-58 and two evaluated 
multilevel interventions (two-level: n=1, 6.3%59; three-level: n=1, 6.3%52). Two studies 
reported on the effect of suicide prevention interventions on completed suicides (12.5%),47,52 
seven studies on attempted suicides (43.8%)53-59 and seven studies reported on both 
(43.8%).41-43,45,48,49,51 In five of the 16 studies, the setting was an outpatient specialty mental 
health institution (31.3%),42,45,48,56,57 in four studies an emergency department (25.0%)49,53-55 
or a community facility (25.0%) was involved,43,51,52,59 and in three studies the setting was a 
psychiatric ward of a general hospital (18.8%).41,47,58 Nine of 16 studies (56.3%) reported on 
participants who received treatment in a hospital (emergency room or psychiatric department) 
after non-fatal suicidal behaviour.41,42,47-49,53-56 In four studies (25.0%) professional groups, 
such as soldiers, veterans and police officers, were involved.45,52,57,58 Participants from the 
community, such as from schools, were reported in three studies (18.8%).43,51,59 
SYNTHESIS OF RESULTS
Overall meta-analysis
The study of Pearson et al., 2017 reported in person-years and this outcome could not be 
pooled with the outcomes of the other studies. Hence that study was not included in the meta-
analysis. A total of 15 studies were included in the meta-analysis, all together reporting 62 
suicides and 1006 suicide attempts (participants might have attempted suicide multiple times). 
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The first meta-analysis established the overall effect of any kind of suicide prevention 
intervention on combined completed and attempted suicides, here defined as suicidal 
behaviour. Overall meta-analytic regression for this combined effect showed a significant, 
albeit moderate effect, with all studies favouring suicide prevention interventions over control 
conditions. The pooled estimate of effect size was d=-0.495 (95% CI -0.677; -0.313, p<.001). 
The forest plot is shown in Figure 2. 
[ Insert Figure 2 as online data supplement ]
Figure 2. Forest plot suicidal behaviour
Heterogeneity (Q value) of this combined effect of suicide prevention interventions for all 
studies taken together was 32 (df=16, p=.011). The I2 statistic was 50%, indicating moderate 
heterogeneity, sufficiently to use a random model to fit the data, which was done in this 
analysis (Higgins). Because of this Q value and I2 level of heterogeneity of the combined 
outcomes, the further analyses were performed separately for completed suicides and 
attempted suicides.
Completed suicides
For suicide prevention interventions on completed suicides, the pooled estimate was d=-0.535 
(95% CI -0.898; -0.171, p=.004), which is a large, statistically significant effect. This effect is 
larger than the abovementioned combined effect. Q value for these studies was 6 (df=6, 
p=.455). The I2 statistic was 0%, indicating no heterogeneity. This is a robust effect. The 
forest plot is shown below.
21
[ Insert Figure 3 about here ]
Figure 3. Forest plot of completed suicides
Attempted suicides
For suicide prevention interventions on attempted suicides, the pooled estimate was d=-0.449 
(95% CI -0.618; -0.280, p<.001), which is a moderate, statistically significant effect, slightly 
smaller than the above-mentioned combined effect. The forest plot is shown below. The Q 
value for these studies was 37 (df=14, p=.001). The I2 statistic was 62%, indicating large 
heterogeneity. 
[ Insert Figure 4 about here ]
Figure 4. Forest plot of attempted suicides
ADDITIONAL ANALYSIS 
Setting of intervention
In order to establish whether outcomes differ across settings in which suicide prevention 
intervention is provided, a separate pre-envisioned moderator analysis of studies according to 
the type of setting was done. Results are shown separately for completed suicides and 
attempted suicides.
Completed suicides
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For completed suicides, suicide prevention interventions for patients admitted to a psychiatric 
ward in a general hospital show the highest effect: d=-1.082 (95% CI -2.027; -0.137, p=.025). 
This is a large effect. Next effective were community-level interventions, with d=-0.832 (95% 
CI -1.406; -0.259, p=.004), a large effect size. Emergency room setting suicide prevention 
interventions had a small, non-significant effect size of d=-0.289 (95% CI -1.082; 0.503, 
p=.474). Outpatient specialty mental health setting interventions had a worse outcome for 
suicide prevention interventions than the control, with an effect size of d=0.088 (95% CI -
0.655; 0.831, p=.817); this effect was not significant. With the use of a random effects model, 
Q between groups was 5 (df=3, p=.145). 
Attempted suicides
For attempted suicides, outpatient specialty mental health setting interventions showed the 
highest effect: d=-0.705 (95% CI -1.275; -0.135, p=.015). This is a large effect. Next best 
were suicide prevention interventions for patients admitted to a psychiatric ward in a general 
hospital, with d=-0.483 (95% CI -0.892; -0.073, p=.021), a moderate effect size. Community-
level interventions had an effect size of d=-0.324 (95% CI 0.513; -0.136, p=.001) and 
emergency room setting suicide prevention interventions had an effect size of d=-0.319 (95% 
CI -0.528; -0.110, p=.003). Both were small effects. With the use of a random effects model, 
Q between groups was 2 (df=3, p=.565). 
Multilevel suicide prevention interventions
Suicide interventions were labelled as multilevel if they contained elements that were 
performed in different healthcare settings or domains and by different providers. Effect sizes 
in terms of completed suicides differed for multilevel interventions from non-multilevel 
interventions as follows: non-multilevel intervention effects were: d=-0.334 (95% CI -
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0.804;0.136, p=.163) which was a small and non-significant effect. Multilevel interventions 
were: d=-0.832 (95% CI -1.406; -0.259, p=.004), which is a large, significant effect. Q 
between groups was 2 (df=1, p=.188). Effect sizes in terms of attempted suicides differed for 
multilevel interventions from non-multilevel interventions as follows: non-multilevel 
interventions: d=-0.443 (95% CI -0.632; -0.254, p<.001), which was a moderate and 
significant effect. Multilevel interventions were: d=-0.622 (95% CI -1.034; -0.210, p=.003) 
which was a large, significant effect. Q between groups was 0.598 (df=1, p=.438). 
Synergistic effect
The meta-regression analysis examined whether a synergistic effect for multilevel suicide 
prevention interventions could be found on combined outcomes. The analysis showed a 
significant effect of the number of levels in the suicide prevention intervention on effect size 
(Q=4.591, df=1 p=.032). With single-level interventions, the effect size was -0.3, which is a 
small effect. Two-level interventions show an effect size of approximately -0.5, which is 
moderate, and three levels show a large effect, going up to -0.8, as can be seen in Figure 5. 
[ Insert Figure 5 about here ]
Figure 5. Meta-regression of number of intervention levels on the standardised mean 
difference
RISK OF BIAS 
Risk of bias within studies: meta-regression
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As indicated on the Risk of Bias (ROB; Table 3), ROB varied greatly; moreover, there were a 
substantial number of studies with serious ROB. Hence, a meta-regression was performed to 
explore whether the level of ROB in the studies was associated with the effect as found in the 
analysis. The analysis showed that there was no significant association (Q =0.033, df=1 
p=.855). Hence, all studies could be used for the analysis, as was done in this study.
Risk of bias across studies: publication bias
A test for publication bias was performed. The Begg funnel plot with observed and imputed 
studies is shown in Figure 6. It shows that the adjusted estimate is fairly close to the original. 
The Egger test was not significant, indicating symmetry (t(17)=1.620, 95% CI: -2.21; 0.29, 
p=.124). This indicates that no significant publication bias seems to be the case, and the 
reported effect is valid.
[ Insert Figure 6 as Online data supplement ]
Figure 6. Funnel plot
Discussion
The aim of this review was to evaluate the effectiveness of suicide prevention interventions in 
different settings, to compare their relative effectiveness by providing an estimate of their 
effect size, and to explore possible synergism of multilevel interventions in a meta-analysis. 
This systematic review includes 252,932 participants in 16 controlled studies. The meta-
analysis, for the first time, provides a comparative estimate for the effect of different types of 
suicide prevention interventions, based on 15 controlled studies, with 29,071 participants in 
various settings. The meta-analysis, for the first time, provides an estimate of the effect size of 
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suicide prevention interventions based on 15 controlled studies, with 29,071 participants in 
various settings. The findings show that suicide prevention interventions are effective in 
preventing both completed and attempted suicides. The effect size for completed suicides is 
larger than for attempted suicides. It might seem counterintuitive that interventions effective 
against completed suicides do not always prevent suicide attempts, as the greatest risk of 
completed suicide are suicide attempts. However, a possible explanation might be that the 
profile of the patient group that attempts suicide may differ in terms of personality disorder or 
method of suicide. Therefore, it might be that a suicide prevention intervention that is 
effective against one is not automatically as effective against the other outcome. This may be 
related to findings that people who complete suicide, in comparison to people who attempt 
suicide, are more often middle- or elderly-aged men,62,63 and choose lethal means  such as 
hanging  more frequently as the suicide method62 and have fewer psychiatric problems. 
People who attempt suicide are more often younger women,62 and use less lethal means  
such as overdose or cutting  as suicide method and have more psychiatric problems.62 More 
research is needed to whether individuals that complete versus attempt suicide differ with 
regards to the presence of psychiatric disorders.
Differences between completed suicides and attempted suicides can also be identified 
in terms of intervention settings. For completed suicides, suicide prevention interventions for 
patients admitted to a psychiatric ward in a general hospital and community-level 
interventions showed large effects. Interventions in other settings showed no significant 
effect. However, in attempted suicides, suicide prevention interventions delivered in 
outpatient specialty mental health settings showed a large effect and, for patients admitted to a 
psychiatric ward in a general hospital, a moderate effect. Community level and emergency 
room-based interventions had only small effects. It is remarkable that, although an 
intervention provided in an outpatient specialty mental health institution might be very 
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effective in preventing suicide attempts, it might not at all be effective in preventing 
completed suicides. A very tentative explanation is that there are different patient profiles: a) 
patients who require an admission to advert suicide, and b) patients whose suicidality suicidal 
thoughts and behaviour might be related to a personality disorder or coping problems and who 
might benefit more from outpatient treatment. In the latter group, patients might be more 
amenable to interventions that foster individual autonomy. This finding is of high clinical and 
policy relevance as, until now, the general assumption in research has been that the 
interventions will work equally for both outcomes. It underscores the need to be able to 
discern risk for completed suicide from risk for attempted suicide in clinical practice. 
However, making such determinations remains a substantial clinical challenge. 
The findings also show that multilevel interventions are more effective than single 
level interventions and, further, that effect size rises significantly with the number of levels 
involved. Regarding synergism, a synergistic effect of multilevel interventions would ideally 
occur when the combined effect of the interventions is greater than the sum of the individual 
effects. This could be expressed as an exponential relationship between the numbers of 
intervention levels. In this study, a more linear relationship was found. However, as the effect 
sizes were considerable, ranging from -0.3 to -0.5 and -0.8 for the three-level intervention, a 
ceiling effect might have occurred. Although this does not yet provide direct evidence for 
synergism as described above, the findings are promising. In view of the low number of 
studies with more than one level, further research into multilevel interventions is 
recommended. Due to the added value of multilevel interventions and the synergistic 
potential, we recommend the implementation of multilevel suicide prevention interventions 
above one level. 
27
STRENGTHS AND LIMITATIONS
This study is the first to perform a systematic review and meta-analysis evaluating controlled 
studies examining the effect of any kind of suicide prevention intervention and providing an 
estimate of the effect size. The number of participants was high, 252,932, and the focus on 
quantitative outcomes for completed and attempted suicides enabled us to establish clear 
outcomes of high societal relevance. Moreover, despite completed suicides being a very low 
base rate behavior, we found significant results which is probably due to the very large 
number of patients that were included in our study. There were no indications for publication 
bias, and it is not expected that relevant studies were excluded or missed in the review process 
since the authors consulted multiple sources for the identification of studies. With regard to 
limitations, we compared the three intervention conditions that were examined in the 
Wasserman et al. (2015) study43 separately, with the one control condition of their study for 
the meta-analysis, rather than comparing the three interventions together with the control 
condition. This was done to prevent the loss of relevant information, as there were differences 
in the interventions themselves and, importantly, also in their effectiveness in the prevention 
of suicide. A second limitation is that we only included two multilevel interventions in the 
meta-analysis of which one was a two-level intervention and one was a three-level 
intervention. Multilevel interventions should, therefore, be the focus of further research, as the 
current evidence indicates a greater effect of multilevel interventions compared to unilevel 
interventions and synergistic potential. Moreover, completed suicides remain a low base rate 
behavior. This resulted in our study in a less precise estimate of the effect, compared to 
suicide attempts. It is desirable for future research that more studies will examine the effect of 
suicide prevention interventions on preventing completed suicide, as more studies will enable 
more precise estimates of the effects.
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FUTURE RESEARCH
Although the number of participants in this review was high (N=252,932), and the number 
included in the meta-analysis as well (N=29,071), the number of controlled studies reporting 
on completed or attempted suicides identified in this study (N=16) was lower than expected in 
view of the globally rising suicide rates and the 2013 commitment of the World Health 
Organisation Member States for the development of suicide prevention interventions. Many 
studies are non-controlled investigations that report on indirect precursors of suicide such as 
suicidal ideation. This might be due to the fact that suicide is a statistically rare event; 
however, preventing suicide should be the ultimate goal of a suicide prevention intervention. 
We, therefore, recommend future research with controlled designs to further examine the 
effectiveness of suicide prevention interventions  especially multilevel interventions  on 
numbers of completed or attempted suicides. Future research should also examine further 
differential effects across outcomes and across specific characteristics of settings. For 
example, for some people, a psychiatric admission might be very effective in preventing 
suicidal behaviours, while for others it might cause pervasive distress.64 Also, some settings 
may have more effect on prevention of completed suicides, while others may be more 
effective for attempted suicides. More insight is needed into which characteristics contribute 
to making an intervention in a particular setting more or less effective, and in which respect. 
This study shows that the assumption that interventions have the same effect on completed 
and attempted suicides, and in different settings, is no longer valid. A related recommendation 
for future research would be to determine optimal strategies for professionals to discern risk 
for completed suicide from risk for an attempt, as appropriate interventions for each may 
differ. Finally, further research is needed to explore and further improve synergism in 
multilevel interventions.
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CONCLUSION
To conclude, sSuicide prevention interventions are effective in preventing suicidal behavior 
and should be widely implemented. The findings suggest that clinicians should make an 
assessment of whether their patient is at serious risk for completing suicide. This will assist in 
determining the most appropriate treatment: intervention provided in the psychiatric ward of a 
general hospital or, alternatively, prevention of attempted suicide in an outpatient specialty 
mental health clinic. Moreover, multilevel interventions should be the focus of further 
research due to a greater effect and synergistic potential. multilevel interventions should be 
the strategy of choice due to a greater effect and a synergistic potential. 
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Appendix 1: PRISMA Checklist
Section/topic # Checklist item Page 
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or 
both. 
0
ABSTRACT 
Structured 
summary 
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number. 
1
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is 
already known. 
2
Objectives 4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
3
METHODS 
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
4
Eligibility 
criteria 
6 Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving 
rationale. 
4
Information 
sources 
7 Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional 
studies) in the search and date last searched. 
4
Search 8 Present full electronic search strategy for at least one database, 
including any limits used, such that it could be repeated. 
5
Study 
selection 
9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
5
Data collection 
process 
10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators. 
6
Data items 11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made. 
6
Risk of bias in 
individual 
studies 
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used 
in any data synthesis. 
7
Summary 
measures 
13 State the principal summary measures (e.g., risk ratio, 
difference in means). 
8
Synthesis of 
results 
14 Describe the methods of handling data and combining results 
of studies, if done, including measures of consistency (e.g., I2) 
9
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for each meta-analysis. 
Risk of bias 
across studies 
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective reporting 
within studies). 
9
Additional 
analyses 
16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating which 
were pre-specified. 
9
RESULTS 
Study 
selection 
17 Give numbers of studies screened, assessed for eligibility, and 
included in the review, with reasons for exclusions at each 
stage, ideally with a flow diagram. 
10
Study 
characteristics 
18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
10
Risk of bias 
within studies 
19 Present data on risk of bias of each study and, if available, any 
outcome level assessment (see item 12). 
16
Results of 
individual 
studies 
20 For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally 
with a forest plot. 
19
Synthesis of 
results 
21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency. 
19
Risk of bias 
across studies 
22 Present results of any assessment of risk of bias across studies 
(see Item 15). 
23
Additional 
analysis 
23 Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]). 
24
DISCUSSION 
Summary of 
evidence 
24 Summarise the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and 
policymakers). 
24
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review level (e.g., incomplete retrieval of 
identified research, reporting bias). 
27
Conclusions 26 Provide a general interpretation of the results in the context of 
other evidence, and implications for future research. 
29
FUNDING 
Funding 27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review. 
29
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Appendix 2: Search strategy
PubMed
#1 Systematic reviews
(suicide[MeSH Terms] OR suicide[All Fields]) AND (prevention and 
control[Subheading] OR (prevention[All Fields] AND control[All Fields]) OR 
prevention and control[All Fields] OR prevention[All Fields]) AND (methods[MeSH 
Terms] OR methods[All Fields] OR intervention[All Fields]) AND (review[Publication 
Type] OR review literature as topic[MeSH Terms] OR systematic review[All Fields]) 
AND (2011/01/01[PDAT] : 2017/12/15[PDAT])
#2 Clinical trials
(suicide[MeSH Terms] OR suicide[All Fields]) AND (prevention and 
control[Subheading] OR (prevention[All Fields] AND control[All Fields]) OR 
prevention and control[All Fields] OR prevention[All Fields]) AND (methods[MeSH 
Terms] OR methods[All Fields] OR intervention[All Fields]) AND (clinical 
trial[Publication Type] OR clinical trials as topic[MeSH Terms] OR clinical trial[All 
Fields]) AND (2011/01/01[PDAT] : 2017/12/15[PDAT])
The PubMed search strategy for systematic reviews and clinical trials was also translated for 
the PsycINFO and Cochrane databases. 
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1Abstract
Objective: This study provides an estimate of the effect size of suicide prevention 
interventions and evaluates the possible synergistic effects of multilevel interventions. 
Method: A systematic review and meta-analysis were conducted of controlled studies 
evaluating suicide prevention interventions versus control published between 20112017 in 
PubMed, PsycINFO, and Cochrane databases. Data extraction and risk of bias assessment 
according to ROBINS criteria were performed by independent assessors. Cohens delta was 
calculated by a random meta-analysis on completed and attempted suicides as outcomes. 
Meta-regression explored a possible synergistic effect in multilevel interventions. 
PROSPERO ID number: X. Results: The search yielded 16 controlled studies with a total of 
252,932 participants. The meta-analysis was performed in 15 studies with 29,071 participants. 
A significant effect was found for suicide prevention interventions on completed suicides (d=-
0.535, 95% CI -0.898; -0.171, p=.004) and on suicide attempts (d=-0.449, 95% CI -0.618; -
0.280, p<.001). Regarding the synergistic effect of multilevel interventions, meta-regression 
showed a significantly higher effect related to the number of levels of the intervention 
(p=.032). Conclusions: Suicide prevention interventions are effective in preventing 
completed and attempted suicides and should be widely implemented. Further research should 
focus on multilevel interventions due to their greater effects and synergistic potential. Further 
research is also needed into risk appraisal for completed versus attempted suicide, as the 
preferred intervention strategy differs with regard to both outcomes. 
Keywords: suicide prevention, intervention, effectiveness, synergism, systematic review, 
meta-analysis, controlled studies
2Introduction 
RATIONALE
Suicide is a worldwide major public health problem, with 800,000 suicides annually.1 Suicide 
attempts are among the most important known predictors of completed suicides, and occur 
even more often.1,2 Since the 2013 commitment of the World Health Organisation Member 
States to work towards suicide prevention,3 ample national strategies and suicide prevention 
interventions have been developed and overviews of them provided in systematic reviews.4-17 
The effectiveness of suicide prevention interventions in reducing suicide rates is found in 
certain settings, but not (yet) in others.4,8,11,12 In 2005, Mann et al. performed a systematic 
review pertaining to suicide prevention strategies in general;18 this review was updated by 
Zalsman et al. in 2016.4 Despite growing evidence for the effectiveness of several suicide 
prevention strategies, until now a comparative estimate for the effect of different types of 
interventions has not yet been provided. Also, it remains unclear which strategy is the most 
effective and if the setting of intervention is relevant to the effect. 
It has been argued that effective action towards reducing suicide would need combined 
interventions by different providers in multiple domains3,4,18  so-called multilevel 
interventions.19,20 For example, at the community level, this could be accomplished by: (1) 
providing gatekeepers such as teachers and with priests training others to aid recognition of 
persons potentially at risk; (2) combining it with a publicity campaign21,22 and with (3) 
instructions to the press on how to publish information on suicides. In addition, on the 
primary care level, general practitioners could be trained on how to address suicidal thoughts 
and behaviour in patients. Indications of the effectivity of multilevel interventions were found 
in non-controlled studies;20,23,24 however, this effect was not replicated in one of the very few 
published randomised controlled trials examining the effectiveness of a multilevel 
intervention in preventing suicidal behaviour.22 
3Multilevel interventions have been suggested as having synergistic potential,19 
meaning that the effect of the combined parts of the intervention might create a stronger effect 
than the sum of the individual effects of the interventions. Hegerl et al. (2006) observed, 
during the implementation of a four-level community-based suicide prevention intervention, 
that general practitioners were more motivated to participate in the training sessions because 
the ongoing public campaign aimed at destigmatisation prompted their patients to present 
themselves with possible depressive symptoms and suicidal ideation.24 Synergistic 
interactions between intervention levels were also suggested by a qualitative study on 
multilevel suicide prevention interventions in four European countries.25 However, thus an 
estimate of a possible synergistic effect has not been provided.19,20 
OBJECTIVES 
This study has three objectives: 
1. To establish an estimate of the effect of suicide prevention interventions for completed 
suicides and suicide attempts;
2. To explore if the setting of intervention is associated with different effect sizes;
3. To explore if multilevel interventions have synergistic effects.
Methods
PROTOCOL AND REGISTRATION
The study protocol is registered in PROSPERO, the international prospective register of 
systematic reviews of the University of York (www.crd.york.ac.uk/prospero/) and is 
accessible under ID number X. The Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) statement for transparent reporting was followed.26 The PRISMA 
checklist is included in Appendix 1.
4ELIGIBILITY CRITERIA 
Studies were considered eligible if suicides and/or suicide attempts were included as an 
outcome and if a suicide prevention intervention was compared with a control group or 
period. Studies were included when randomisation was performed between patients or 
between practice settings,27 but could also be Controlled Cohort Studies (CCS), Controlled 
Before After studies (CBAs), Controlled Interrupted Time Series (CITS), or Interrupted Time 
Series (ITS) studies. Principal outcomes were suicide attempts and completed suicides and 
had to be defined in quantitative measures in order to make meta-analysis possible. The 
exclusion criterion was the inclusion of self-harm (non-suicidal self-injury; SH) in the target 
group for the intervention. 
INFORMATION SOURCES
Potentially eligible studies were identified by searching the databases PubMed, PsycINFO 
and the total database of the Cochrane Library (including Cochrane Database of Systematic 
Reviews, Database of Abstracts of Reviews of Effect, Cochrane Central Register of 
Controlled Trials, Health Technology Assessment Database, and NHS Economic Evaluation 
Database). As this study further elaborates on the systematic review of van der Feltz-Cornelis, 
which was published in 2011, our search extended from January 2011 through December 
2017.19 The reference lists of reviews were checked for missed studies. Personal files of the 
workgroup members were checked for relevant publications, and experts from the section 
suicidology and suicide prevention of the European Psychiatric Association 
(https://suicidologysection.org) and from the European Alliance Against Depression (EAAD) 
(www.eaad.net) were consulted about relevant publications in order to identify additional 
studies not found by our search strategy.
5SEARCH
A search was performed of systematic reviews of randomised or controlled studies in the field 
of suicide prevention interventions with MeSH terms and free text terms for suicide 
prevention AND intervention AND systematic review. A second search was run with 
suicide prevention AND intervention AND clinical trial. Randomised or controlled 
studies in the field of suicide prevention interventions were included. Only studies with a 
primary focus on suicide reduction were selected. The search strategy for PubMed is shown in 
Appendix 2. It was adapted for the other databases. We did not use language restrictions to 
minimise Tower of Babel Bias.28
STUDY SELECTION
After identifying studies from database searching and additional sources, duplicate records 
were removed. The titles and abstracts of the records were assessed to determine eligibility in 
a first screening and the full-text articles were assessed for eligibility in a second screening. 
The screenings were performed in duplicate (X and X). If the two independent assessors had 
disagreements in coding, a third assessor (X) was consulted to make the final decision. 
DATA COLLECTION PROCESS
An overview of participants, interventions, comparisons, outcomes and study design (PICOS) 
is shown in Tables 1 and 2. The extraction of data was performed independently by two 
researchers (X and X). In the case of non-consensus, a third assessor (X) was consulted to make 
the final decision. 
6DATA ITEMS
Two tables are provided, one for studies evaluating completed suicides and one for suicide 
attempts. Interventions are categorised as one level or multilevel, and the number of levels is 
provided by the third researcher of this study (X). The data items of each study are described 
below.
Type of study design
Included studies could be Randomised Controlled Trials, Cluster Randomised Controlled 
Trials, Controlled Cohort studies (CCs), Controlled Before After studies (CBAs), Controlled 
Interrupted Time Series (CITS) or Interrupted Time Series (ITS) studies.
Details of the intervention
Suicide prevention strategies may include community approaches, psychotherapeutic 
interventions, pharmacotherapeutic and multilevel interventions, with the prerequisite for 
inclusion that the intervention is sufficiently described to classify it as a suicide prevention 
intervention aimed at reducing attempted or completed suicides. The number of intervention 
levels was taken into account in the analysis, as was the setting, which could be the 
community, emergency room, outpatient specialty mental health setting or a psychiatric ward 
in a general hospital.
Patient groups
Targeted populations could be suicidal persons in the various settings mentioned above; 
psychiatric patients, children and adolescents, older people, certain professional groups such 
as veterans, as well as ethnic minorities. There was no restriction on the kind of mental 
disorders.
7Outcome definitions
Outcomes were completed or attempted suicides in quantitative measures, as defined by 
healthcare professionals (hospital records, questionnaires, or interview) or coroners records, 
as can be seen in Table 1 and 2. Measurement instrument and follow-up time were recorded. 
Level of evidence
Level of evidence was defined according to the criteria of the Oxford Centre of Evidence-
Based Medicine.29
RISK OF BIAS IN INDIVIDUAL STUDIES
The quality of each study was determined by assessing the risk of bias in both the study and 
outcome level. Risk of bias (ROB) assessment was performed by two assessors (X, X) who 
discussed beforehand the required approach based upon the Cochrane Risk Of Bias in Non-
randomised Studies  of Interventions (ROBINS-I)30 and double-scored one of the articles. As 
no particularities in assessment were observed, all the other studies were individually assessed 
by the two assessors. In ROB appraisal, as confounding factors, co-therapies such as 
pharmacotherapy or psychotherapy on top of the suicide prevention intervention were 
considered, as well as including both suicidal persons and persons performing self-harm in the 
study. In the case of RCTs, the most important Cochrane quality criterion, namely 
randomisation,31,32 was explicitly mentioned. The results of this risk-of-bias assessment are 
shown in Table 3. Furthermore, a meta-regression explored if an association existed between 
the risk of bias of the studies and the effect size of the interventions.
8SUMMARY MEASURES
We used the rates of completed or attempted suicides in intervention and control conditions 
for pooling. We calculated the effect sizes for each study using Comprehensive Meta-analysis 
version 2.33 We chose to take the following outcome measures into account for the analysis:
1) As a first step, the combined effect on completed and attempted suicides was analysed and 
labeled suicidal behaviour. 
2) Subsequently, separate analyses on those two outcomes were performed, with larger 
negative effect sizes being an improvement compared to smaller negative effect sizes, and 
effect sizes above zero a deterioration.
The effects were presented in terms of standardised effect sizes (Cohen's d). These effect sizes 
indicate by how many standard deviations the intervention group performed better than the 
control group. The effect size d is calculated by subtracting the average score of the control 
group (Mc) from the average score of the experimental group (Me) and dividing the raw 
difference score by the pooled standard deviation of the experimental and control group.34 An 
effect size of 0.5 indicates that the mean of the experimental group is half a standard deviation 
larger than the mean of the control group. In general, one considers an effect size of 0.561.2 
a large clinical effect, an effect size of 0.330.55 moderate, and an effect size of 00.32 as 
small.35,36
SYNTHESIS OF RESULTS
We performed a random-effects meta-analysis to examine the effectiveness of interventions 
on suicide prevention.37 Between-study heterogeneity was assessed using the Q-statistic,38 
which reflects the observed dispersion. In order to quantify this dispersion, the I2 statistic was 
used, which describes the percentage of total variation across studies that is the result of 
9heterogeneity rather than of chance. All statistical pooling was conducted using 
Comprehensive Meta-Analysis, version 2.33
RISK OF BIAS ACROSS STUDIES
Publication bias was examined by constructing a Begg funnel plot39 and running a Stern & 
Egger test.40 
ADDITIONAL PRE-ENVISIONED MODERATOR ANALYSES
The setting of the intervention was explored as a moderator. Also, suicide prevention 
interventions were labelled as multilevel if they contained elements that were performed in 
different settings and by different providers.19 Effect sizes of multilevel interventions were 
compared with effect sizes of non-multilevel interventions. In the case of multilevel 
interventions, an estimate of the effect was made to explore the potential of synergism by 
meta-regression. In the case of synergism, an exponential effect was expected. 
Results 
STUDY SELECTION
The database search identified 442 records. In addition, 172 records were identified by 
consulting suicide prevention experts (19 records) and by identifying studies from literature 
reviews about suicide prevention interventions (153 records). After removal of duplicates, 447 
records remained. After screening the records on title and abstract, 389 records were excluded 
and 58 articles were assessed for eligibility based on the full text (46 through database 
searching and 12 through additional sources). Finally, 16 studies were included in the 
systematic review. The study of Pearson et al. (2017) could not be pooled due to different 
10
outcomes, namely person-years. Hence, 15 studies were included in the meta-analysis, as is 
shown in Figure 1. 
[ Insert Figure 1 about here ]
Figure 1. PRISMA flow diagram (2009) of the different phases of the systematic review
STUDY CHARACTERISTICS 
An overview of the study and characteristics with regards to participants, interventions, 
comparisons, outcomes and study design (PICOS) for studies evaluating completed suicide 
and suicide attempts are presented in Tables 1 and 2. A total of 16 studies were included in 
the systematic review. Of these studies, 14 examined a unilevel suicide prevention 
intervention and two a multi-level intervention. Of the two multi-level interventions, one 
study included completed suicides as an outcome measure and one study attempted suicides.
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Table 1. Overview of participants, interventions, comparisons, outcomes, and study design (PICOS) for studies evaluating completed suicide
Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Unilevel N=234,589 d=-0.334 (95% CI -0.804; 
0.136, p=.163)
Vijayakumar et 
al., 201141
RCT (1b) - 622 participants in one 
general hospital (Admitted 
GHP)
- India
Suicide attempters 
>12 years, admitted 
in a general hospital
Brief intervention and contact 
(BIC) (n=302) versus TAU 
(n=320)
- Study 
questionnaire
- 18 months 
Significant less suicides in BIC 
compared to control group (d=
-1.193, CI -2.336; -0.051, 
p=.041).
Hvid et al., 
201142 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark
Suicide attempters 
arriving at the 
hospital ED and 
clinical departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital 
records
- 12 months
No significant difference 
between OPAC and control 
group (d=0.348, CI -0.989; 
1.685, p=.610).
Wasserman et 
al., 201543
Cluster-
RCT (1b)
- 8,182 participants in 168 
schools (Community level)
- European Union (EU) 
countries
Adolescent pupils 
recruited from EU 
schools
Question, Persuade and Refer 
(n=1,978) and Youth Aware 
of Mental Health Programme 
(n=1,987) and screening by 
professionals (n=1,961) versus 
exposure to educational 
posters in the classroom 
(n=2,256)
- Paykel 
Hierarchical 
Suicidal 
Ladder44
- 12 months
No significant difference 
between intervention groups 
and a control group (no 
participants completed suicide 
during the study period).c
Rudd et al., 
201545
RCT (1b) - 108 participants in one 
Military Hospital 
(Outpatient SMHI)
- USA
Active-duty Army 
soldiers with 
suicide attempt or 
ideation 
Brief cognitive-behavioural 
therapy (BCBT) (n=54) 
versus TAU (n=54)
- Suicide 
Attempt Self-
Injury 
Interview46
- 24 months
No significant difference 
between BCBT and control 
group (d=0.000, CI -1.538; 
1.538, p=1.000).
Amadéo et al., 
201547
RCT (1b) - 190 participants in one 
hospital psychiatric 
emergency department 
(Admitted GHP)
- French Polynesia
Patients who sought 
help due to non-
fatal suicidal 
behaviour 
Brief Intervention and Contact 
(BIC) (n=90) versus TAU 
(n=100) 
- Coroners 
records
- 18 months 
No significant difference 
between BIC and control group 
(d=-0.841, CI -2.522; 0.841, 
p=.327).
Lahoz et al., 
201648 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
Suicide attempters 
arriving at the 
Outreach, Problem solving, 
Adherence, Continuity 
- Hospital 
records
- 60 months
No significant difference 
between OPAC and control 
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
- Denmark hospital ED and 
clinical departments
(OPAC) program (n=65) 
versus TAU (n=60)
group (d=-0.043, CI -1.140; 
1.054, p=.939).
Miller et al., 
201749
PP (2c) - 1,376 participants in 8 
hospital EDs (ED)
- USA
Adults with recent 
suicide attempt or 
ideation presented 
to hospital ED 
Emergency Department Safety 
Assessment and Follow-up 
Evaluation (ED-SAFE) + 
Screening (n=502) or 
Screening alone (n=377) 
versus TAU (n=497)
- Columbia 
Suicide Severity 
Rating Scale50 + 
medical records
- 12 months
No significant difference 
between ED-SAFE and control 
group (d=-0.289, CI -1.082; 
0.503, p=.474).
Pearson et al., 
201751 b
Cluster-
RCT (1b)
- 223,861 participants in 
the community 
(Community level)
- Sri Lanka 
People aged 14 
years or older in 
households living in 
rural villages
Distribution and promotion of 
household lockable pesticide 
storage (n=114,168) versus 
usual practice (n=109,693)
- Hospital, 
community and 
coroner data
- 36 months
No significant difference 
between the intervention group 
and the control group.c
Multilevel
Three-level N=14,309 d=-0.832 (95% CI -1.406; 
-0.259, p=.004)
Mishara et al., 
201252
PP (2c) - 14,309 participants of all 
Montreal police and rest of 
Quebec police (QP) 
(Community level)
- Canada
Montreal police 
(MP) officers 
Together for Life in Montreal 
police (n=4,178) versus no 
intervention in rest of Quebec 
police (n=10,131)
- Quebec 
Coroners 
Office on all 
police suicides
- 144 months
Significant fewer suicides in 
intervention compared to 
control group (d=-0.832, CI 
-1.406; -0.259, p=.004).
Note: a The study of Lahoz et al., 2016 is a 5-year followup of the study of Hvid et al., 2011. 
b The study of Pearson et al., 2017 reported in person-years and was not included in the meta-analysis. 
c The study of Wasserman et al., 2015 and Pearson et al., 2017 were not included in the meta-analysis to completed suicides; effect size is therefore not provided in the table.
Abbreviations: ED = emergency department. GHP = psychiatric ward in general hospital. OPAC = suicide prevention intervention named Outreach, Problem-solving, Adherence, Continuity 
programme. PS = suicide prevention intervention named Screening by professionals. PP = pre-post design. QPR = suicide prevention intervention named Question, persuade and refer. RCT = 
randomised controlled trial. SMHI = specialty mental health institution. TAU = treatment as usual. YAM = suicide prevention intervention named Youth aware of mental health programme. 
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Table 2. Overview of participants, interventions, comparisons, outcomes, and study design (PICOS) for studies evaluating attempted suicide
Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Unilevel N=237,387 d=-0.443 (95% CI -0.632 
;0.254, p<.001)
Hassanian-
Moghaddam et 
al., 201153
RCT (1b) - 2,113 participants in one 
poison Hospital ED (ED)
- Iran 
Suicide attempters 
by self-poisoning 
>12 years
Postcard intervention 
(n=1,043) versus TAU 
(n=1,070)
- Study 
questionnaire + 
hospital records
- 12 months
Significant less suicide attempts 
in intervention compared to 
control group (d=-0.306, CI 
-0.544; -0.069, p=.012).
Vijayakumar et 
al., 201141
RCT (1b) - 622 participants in one 
general hospital (Admitted 
GHP)
- India
Suicide attempters 
>12 years, 
admitted in a 
general hospital
Brief intervention and contact 
(BIC) (n=302) versus TAU 
(n=320)
- Study 
questionnaire
- 18 months 
No significant difference 
between BIC and control group 
(d=-0.399, CI -0.871; 0.073, 
p=.097).
Hvid et al., 
201142a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark 
Suicide attempters 
arriving at the 
hospital ED and 
clinical 
departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital records
- 12 months
Significant less suicide attempts 
in OPAC compared to control 
group (d=-0.784, CI -1.434; 
-0.133, p=.018).
Cebrià et al., 
201354
CCS (3b) - 514 participants in two 
hospital emergency 
departments (ED)
- Spain
Suicide attempters 
discharged from 
ED
Systematic one-year telephone 
follow-up (n=296) versus 
TAU (n=218)
- Medical records
- 12 months 
Significant less suicide attempts 
in intervention compared to 
control group (d=-0.587, CI 
-0.935; -0.239, p=.001).
Mousavi et al., 
201455
RCT (1b) - 139 participants in one 
hospital ED (ED)
- Iran 
Suicide attempters 
>15 years, 
admitted to 
hospital ED
Brief interventional contact 
(BIC) (n=69) versus TAU 
(n=70)
- Study 
questionnaire
- 6 months
No significant difference 
between BIC and control group 
(d=-0.781, CI -2.003; 0.442, 
p=.211).
Wasserman et 
al., 201543
Cluster-
RCT (1b)
- 8,182 participants in 168 
schools (Community level)
- European Union (EU) 
countries
Adolescent pupils 
recruited from EU 
schools
Question, Persuade and Refer 
(n=1,978) and Youth Aware 
of Mental Health Program 
(n=1,987) and screening by 
professionals (n=1,961) versus 
exposure to educational 
posters in the class room 
(n=2,256)
- Paykel 
Hierarchical 
Suicidal Ladder44
- 12 months
Significant less suicide attempts 
in YAM compared to control 
group (d=-0.424, CI -0.768; 
-0.079, p=.016). No significant 
difference between PS and 
control group (d=-0.218, CI
-0.524; 0.088, p=.163). No 
significant difference between 
QPR and control group (d=
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
-0.170, CI -0.467; 0.128, 
p=.264).
Rudd et al., 
201545
RCT (1b) - 108 participants in one 
military Hospital 
(Outpatient SMHI)
- USA
Active-duty Army 
soldiers with 
suicide attempt or 
ideation 
Brief cognitive-behavioural 
therapy (BCBT) (n=54) 
versus TAU (n=54)
- Suicide Attempt 
Self-Injury 
Interview46
- 24 months
Significant less suicide attempts 
in BCBT compared to control 
group (d=-0.535, CI -1.033; 
-0.037, p=.035).
Gysin-Maillart 
et al., 201656
RCT (1b) - 103 participants in one 
psychiatric department 
General Hospital 
(Outpatient SMHI)
- Switzerland
Suicide attempters 
admitted to ED
Attempted Suicide Short 
Intervention Programme 
(ASSIP) (n=56) versus TAU 
(n=47)
- Questionnaire
- 24 months
Significant less suicide attempts 
in ASSIP compared to control 
group (d=-1.746, CI -2.333; 
-1.159, p<.001).
Lahoz et al., 
201648 a
RCT (1b) - 125 participants in one 
psychiatric outpatient 
setting (Outpatient SMHI) 
- Denmark
Suicide attempters 
arriving at the 
hospital ED and 
clinical 
departments
Outreach, Problem solving, 
Adherence, Continuity 
(OPAC) programme (n=65) 
versus TAU (n=60)
- Hospital records
- 60 months
No significant difference 
between OPAC and control 
group (d=-0.146, CI -0.585; 
0.294, p=.516).
Goodman et al., 
201657
RCT (1b) - 47 participants in one 
veterans outpatient 
medical center (Outpatient 
SMHI)
- USA
High risk suicidal 
veterans, aged 18-
55 years
Dialectical Behavioral 
Therapy (DBT) (n=27) versus 
TAU (n=20)
- Columbia
Suicide Severity 
Rating Scale50
- 12 months
No significant difference 
between DBT and control 
group (d=-0.322, CI -1.146; 
0.503, p=.444).
Bryan et al., 
201758
RCT (1b) - 72 participants in one 
military medical clinic 
(Admitted GHP)
- USA
Active duty U.S. 
Army Soldiers, 
aged 18+ with 
suicidal ideation 
or attempt 
Crisis Response Planning 
standard (CRP-s) (n=23) and 
Crisis Response Planning 
enhanced (CRP-e) (n=24) 
versus Contract for Safety 
(CfS) (n=25)
- Suicide Attempt 
Self-Injury 
Interview46
- 6 months 
No significant difference 
between CRP and control group 
(d=-0.740, CI -1.567; 0.088, 
p=.080).
Miller et al., 
201749
PP (2c) - 1,376 participants in 8 
hospital EDs (ED)
- USA
Adults with recent 
suicide attempt or 
ideation presented 
to hospital ED 
Emergency Department Safety 
Assessment and Follow-up 
Evaluation (ED-SAFE) + 
Screening (n=502) or 
Screening alone (n=377) 
versus TAU (n=497)
- Columbia 
Suicide Severity 
Rating Scale50 + 
medical records
- 12 months
No significant difference 
between ED-SAFE and control 
group (d=-0.156, CI -0.326; 
0.014, p=.072).
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Study Design and 
level of 
evidence
Setting (classification), 
total N and country
Population Intervention (n) and contrast 
(n)
Outcome-
assessment and 
followup time
Effect size
Pearson et al., 
201751 b
Cluster-
RCT (1b)
- 223,861 participants in 
the community 
(Community level)
- Sri Lanka
People aged 14 
years or older in 
households living 
in rural villages
Distribution and promotion of 
household lockable pesticide 
storage (n=114,168) versus 
usual practice (n=109,693)
- Hospital, 
community and 
coroner data
- 36 months
No significant difference 
between the intervention group 
and the control group.c
Multilevel
Two-level N=1,046 d=-0.622 (95% CI -1.034;
-0.210, p=.003)
Schilling et al., 
201659 
Cluster-
RCT (1b)
- 1,046 participants in 16 
technical high school 
(Community level)
- USA
Ninth grade 
students in 
technical high 
school 
Signs of Suicide (SOS) 
(n=650) versus wait list 
control group (n=396)
- Single-item 
measure from the 
Youth Risk 
Behavior Survey60
- 3 months
Significant less suicide attempts 
in SOS compared to control 
group (d=-0.622, CI -1.034; 
-0.210, p<.003).
Note: a The study of Lahoz et al., 2016 is a 5-year follow-up of the study of Hvid et al., 2011. 
b The study of Pearson et al., 2017 reported in person-years and was not included in the meta-analysis. 
c The study of Pearson et al., 2017 was not included in the meta-analysis to suicide attempts; effect size is therefore not provided in the table.
Abbreviations: CCS = case-control study. ED = emergency department. GHP = psychiatric ward in general hospital. OPAC = suicide prevention intervention named Outreach, Problem solving, 
Adherence, Continuity programme. PS = suicide prevention intervention named Screening by professionals. PP = pre-post design. QPR = suicide prevention intervention named Question, 
persuade and refer. RCT = randomised controlled trial. SMHI = specialty mental health institution. TAU = treatment as usual. YAM = suicide prevention intervention named Youth aware of 
mental health programme.
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RISK OF BIAS WITHIN STUDIES
The quality ratings of the studies are shown in Table 3. Thirteen studies were randomised 
studies (RCTs). Two out of 16 studies (12.50%) had a low overall risk of bias, meaning that 
these studies were comparable to a well-performed randomised trial.61 Nine studies had a 
moderate overall risk of bias (56.25%), meaning that these studies provided sound evidence 
for a non-randomised study but cannot be considered comparable to a well-performed 
randomized trial.61 Five studies (31.25%) had a serious overall risk of bias, meaning that 
these studies had some important problems.61 No studies showed a critical risk of bias. All 
studies were considered of sound quality according to the guidelines of the Oxford Centre of 
Evidence-Based Medicine.29 Hence, all studies were used in the analyses. 
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Table 3. Risk of bias within studies 
Study Random-
isation
Confound-
ing
Selection of 
participants
Classifi-
cation of 
intervention
Deviation 
intended    
intervention
Missing 
data
Measure-
ment of 
outcomes
Selection 
reported 
result
Overall 
bias
Comments
Amadéo et 
al., 201547 
Yes Low Low Low Low Moderate Low Low Moderate Two-tailed test in spite of the apparently expected 
direction of the effect; small sample size; missing 
data.
Bryan et al., 
201758 
Yes Low Moderate Low Moderate Low Low Low Moderate Small sample size (N=97) and delay in 
interventions due to recruitment 
suspension (recruitment goal was N=360). 
Cebrià et al., 
201354 
No Serious Low Low Low Low Moderate Low Serious No information about SH; outcome measure could 
have been influenced by knowledge of the 
intervention received in the experimental setting 
(change in 2008).
Goodman et 
al., 201657 
Yes Moderate Low Low Low Serious Low Low Serious A high number of drop-out, no ITT/NTT; no 
information about SH.
Gysin-
Maillart et al., 
201656
Yes Low Low Low Low Moderate Low Low Moderate Missing data due to drop-out.
Hassanian-
Moghaddam 
et al., 201153 
Yes Low Low Low Low Low Low Low Low Good quality study. 
Hvid et al., 
201142 
Yes Low Low Moderate Low Low Moderate Low Moderate Single-blind study; one catchment area so people 
might, by chance, know each other or meet in the 
hospital.
Lahoz et al., 
201648 
Yes Low Low Low Low Low Low Low Low Completed and attempted suicide was taken 
together as an outcome.
Miller et al., 
201749 
No Serious Low Low Low Low Low Moderate Serious Time might have influenced outcomes, time and 
site (probably) not in final analysis, no information 
about validity and reliability measures; possible 
selection of analysis/covariates.
Mishara et 
al., 201252 
No Moderate Serious Moderate Low Moderate Low Low Serious Various interventions in different fields, therefore 
no clearly defined intervention; no outcome data at 
follow-up; missing data.
Mousavi et 
al., 201455 
Yes Low Low Moderate Low Low Moderate Low Moderate Randomisation after the first interview; 
randomisation, missing data and assessment of 
information are not clearly described.
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Pearson et al., 
201751 
Yes Moderate Low Low Low Low Low Low Moderate Cluster RCT, although corrected in analyses.
Rudd et al., 
201545 
Yes Low Low Low Low Low Low Moderate Moderate Multiple analyses of the intervention-outcome 
relationship not registered; no significant effect on 
Fisher exact (two-tailed); analysis selection is 
possible.
Schilling et 
al., 201659
Yes Moderate Low Low Low Serious Moderate Low Serious Cluster RCT; only significant demographics were 
included; proportions of participants not given, but 
probably contrary; more missing items at pre-test; 
self-assessment.
Vijayakumar 
et al., 201141 
Yes Low Low Low Low Moderate Moderate Low Moderate Some 5-10% lost to follow-up; more missing items 
in TAU-group which decreases the effect; potential 
bias in the measurement of outcomes.
Wasserman et 
al., 201543
Yes Low Low Low Low Moderate Moderate Low Moderate Cluster RCT; missing data; self-assessment.
Note: Confounding = pre-intervention bias due to confounding. Selection of participants = pre-intervention bias in the selection of participants into the study. Classification of intervention = at-
intervention bias in classification of interventions. Deviation intended intervention = post-intervention bias due to deviations from intended interventions. Missing data = Post-intervention bias 
due to missing data. Measurement of outcomes = Post-intervention bias in measurement of outcomes. Selection reported result = Post-intervention bias in the selection of the reported result.61
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RESULTS OF INDIVIDUAL STUDIES
A total of 16 studies with 252,932 participants were selected for the systematic review. All 
studies were published in the time period of 20112017. Thirteen studies were (cluster) 
randomised controlled trials (81.3%),41-43,45,47,48,51,53,55-59 two studies were a pre-post design 
study (12.5%),49,52 and one study was a case-controlled design (6.3%).54 Fourteen 
interventions evaluated unilevel interventions (87.5%),41-43,45,47-49,51,53-58 and two evaluated 
multilevel interventions (two-level: n=1, 6.3%59; three-level: n=1, 6.3%52). Two studies 
reported on the effect of suicide prevention interventions on completed suicides (12.5%),47,52 
seven studies on attempted suicides (43.8%)53-59 and seven studies reported on both 
(43.8%).41-43,45,48,49,51 In five of the 16 studies, the setting was an outpatient specialty mental 
health institution (31.3%),42,45,48,56,57 in four studies an emergency department (25.0%)49,53-55 
or a community facility (25.0%) was involved,43,51,52,59 and in three studies the setting was a 
psychiatric ward of a general hospital (18.8%).41,47,58 Nine of 16 studies (56.3%) reported on 
participants who received treatment in a hospital (emergency room or psychiatric department) 
after non-fatal suicidal behaviour.41,42,47-49,53-56 In four studies (25.0%) professional groups, 
such as soldiers, veterans and police officers, were involved.45,52,57,58 Participants from the 
community, such as from schools, were reported in three studies (18.8%).43,51,59 
SYNTHESIS OF RESULTS
Overall meta-analysis
The study of Pearson et al., 2017 reported in person-years and this outcome could not be 
pooled with the outcomes of the other studies. Hence that study was not included in the meta-
analysis. A total of 15 studies were included in the meta-analysis, all together reporting 62 
suicides and 1006 suicide attempts (participants might have attempted suicide multiple times). 
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The first meta-analysis established the overall effect of any kind of suicide prevention 
intervention on combined completed and attempted suicides, here defined as suicidal 
behaviour. Overall meta-analytic regression for this combined effect showed a significant, 
albeit moderate effect, with all studies favouring suicide prevention interventions over control 
conditions. The pooled estimate of effect size was d=-0.495 (95% CI -0.677; -0.313, p<.001). 
The forest plot is shown in Figure 2. 
[ Insert Figure 2 as online data supplement ]
Figure 2. Forest plot suicidal behaviour
Heterogeneity (Q value) of this combined effect of suicide prevention interventions for all 
studies taken together was 32 (df=16, p=.011). The I2 statistic was 50%, indicating moderate 
heterogeneity, sufficiently to use a random model to fit the data, which was done in this 
analysis (Higgins). Because of this Q value and I2 level of heterogeneity of the combined 
outcomes, the further analyses were performed separately for completed suicides and 
attempted suicides.
Completed suicides
For suicide prevention interventions on completed suicides, the pooled estimate was d=-0.535 
(95% CI -0.898; -0.171, p=.004), which is a large, statistically significant effect. This effect is 
larger than the abovementioned combined effect. Q value for these studies was 6 (df=6, 
p=.455). The I2 statistic was 0%, indicating no heterogeneity. This is a robust effect. The 
forest plot is shown below.
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[ Insert Figure 3 about here ]
Figure 3. Forest plot of completed suicides
Attempted suicides
For suicide prevention interventions on attempted suicides, the pooled estimate was d=-0.449 
(95% CI -0.618; -0.280, p<.001), which is a moderate, statistically significant effect, slightly 
smaller than the above-mentioned combined effect. The forest plot is shown below. The Q 
value for these studies was 37 (df=14, p=.001). The I2 statistic was 62%, indicating large 
heterogeneity. 
[ Insert Figure 4 about here ]
Figure 4. Forest plot of attempted suicides
ADDITIONAL ANALYSIS 
Setting of intervention
In order to establish whether outcomes differ across settings in which suicide prevention 
intervention is provided, a separate pre-envisioned moderator analysis of studies according to 
the type of setting was done. Results are shown separately for completed suicides and 
attempted suicides.
Completed suicides
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For completed suicides, suicide prevention interventions for patients admitted to a psychiatric 
ward in a general hospital show the highest effect: d=-1.082 (95% CI -2.027; -0.137, p=.025). 
This is a large effect. Next effective were community-level interventions, with d=-0.832 (95% 
CI -1.406; -0.259, p=.004), a large effect size. Emergency room setting suicide prevention 
interventions had a small, non-significant effect size of d=-0.289 (95% CI -1.082; 0.503, 
p=.474). Outpatient specialty mental health setting interventions had a worse outcome for 
suicide prevention interventions than the control, with an effect size of d=0.088 (95% CI -
0.655; 0.831, p=.817); this effect was not significant. With the use of a random effects model, 
Q between groups was 5 (df=3, p=.145). 
Attempted suicides
For attempted suicides, outpatient specialty mental health setting interventions showed the 
highest effect: d=-0.705 (95% CI -1.275; -0.135, p=.015). This is a large effect. Next best 
were suicide prevention interventions for patients admitted to a psychiatric ward in a general 
hospital, with d=-0.483 (95% CI -0.892; -0.073, p=.021), a moderate effect size. Community-
level interventions had an effect size of d=-0.324 (95% CI 0.513; -0.136, p=.001) and 
emergency room setting suicide prevention interventions had an effect size of d=-0.319 (95% 
CI -0.528; -0.110, p=.003). Both were small effects. With the use of a random effects model, 
Q between groups was 2 (df=3, p=.565). 
Multilevel suicide prevention interventions
Suicide interventions were labelled as multilevel if they contained elements that were 
performed in different healthcare settings or domains and by different providers. Effect sizes 
in terms of completed suicides differed for multilevel interventions from non-multilevel 
interventions as follows: non-multilevel intervention effects were: d=-0.334 (95% CI -
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0.804;0.136, p=.163) which was a small and non-significant effect. Multilevel interventions 
were: d=-0.832 (95% CI -1.406; -0.259, p=.004), which is a large, significant effect. Q 
between groups was 2 (df=1, p=.188). Effect sizes in terms of attempted suicides differed for 
multilevel interventions from non-multilevel interventions as follows: non-multilevel 
interventions: d=-0.443 (95% CI -0.632; -0.254, p<.001), which was a moderate and 
significant effect. Multilevel interventions were: d=-0.622 (95% CI -1.034; -0.210, p=.003) 
which was a large, significant effect. Q between groups was 0.598 (df=1, p=.438). 
Synergistic effect
The meta-regression analysis examined whether a synergistic effect for multilevel suicide 
prevention interventions could be found on combined outcomes. The analysis showed a 
significant effect of the number of levels in the suicide prevention intervention on effect size 
(Q=4.591, df=1 p=.032). With single-level interventions, the effect size was -0.3, which is a 
small effect. Two-level interventions show an effect size of approximately -0.5, which is 
moderate, and three levels show a large effect, going up to -0.8, as can be seen in Figure 5. 
[ Insert Figure 5 about here ]
Figure 5. Meta-regression of number of intervention levels on the standardised mean 
difference
RISK OF BIAS 
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As indicated on the Risk of Bias (ROB; Table 3), ROB varied greatly; moreover, there were a 
substantial number of studies with serious ROB. Hence, a meta-regression was performed to 
explore whether the level of ROB in the studies was associated with the effect as found in the 
analysis. The analysis showed that there was no significant association (Q =0.033, df=1 
p=.855). Hence, all studies could be used for the analysis, as was done in this study.
Risk of bias across studies: publication bias
A test for publication bias was performed. The Begg funnel plot with observed and imputed 
studies is shown in Figure 6. It shows that the adjusted estimate is fairly close to the original. 
The Egger test was not significant, indicating symmetry (t(17)=1.620, 95% CI: -2.21; 0.29, 
p=.124). This indicates that no significant publication bias seems to be the case, and the 
reported effect is valid.
[ Insert Figure 6 as Online data supplement ]
Figure 6. Funnel plot
Discussion
The aim of this review was to evaluate the effectiveness of suicide prevention interventions in 
different settings, to compare their relative effectiveness by providing an estimate of their 
effect size, and to explore possible synergism of multilevel interventions in a meta-analysis. 
This systematic review includes 252,932 participants in 16 controlled studies. The meta-
analysis, for the first time, provides a comparative estimate for the effect of different types of 
suicide prevention interventions, based on 15 controlled studies, with 29,071 participants in 
various settings. The findings show that suicide prevention interventions are effective in 
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preventing both completed and attempted suicides. The effect size for completed suicides is 
larger than for attempted suicides. It might seem counterintuitive that interventions effective 
against completed suicides do not always prevent suicide attempts, as the greatest risk of 
completed suicide are suicide attempts. However, a possible explanation might be that the 
profile of the patient group that attempts suicide may differ in terms of personality disorder or 
method of suicide. Therefore, it might be that a suicide prevention intervention that is 
effective against one is not automatically as effective against the other outcome. This may be 
related to findings that people who complete suicide, in comparison to people who attempt 
suicide, are more often middle- or elderly-aged men,62,63 and choose lethal means  such as 
hanging  more frequently as the suicide method62. People who attempt suicide are more 
often younger women,62 and use less lethal means  such as overdose or cutting  as suicide 
method.62 More research is needed to whether individuals that complete versus attempt 
suicide differ with regards to the presence of psychiatric disorders.
Differences between completed suicides and attempted suicides can also be identified 
in terms of intervention settings. For completed suicides, suicide prevention interventions for 
patients admitted to a psychiatric ward in a general hospital and community-level 
interventions showed large effects. Interventions in other settings showed no significant 
effect. However, in attempted suicides, suicide prevention interventions delivered in 
outpatient specialty mental health settings showed a large effect and, for patients admitted to a 
psychiatric ward in a general hospital, a moderate effect. Community level and emergency 
room-based interventions had only small effects. It is remarkable that, although an 
intervention provided in an outpatient specialty mental health institution might be very 
effective in preventing suicide attempts, it might not at all be effective in preventing 
completed suicides. A very tentative explanation is that there are different patient profiles: a) 
patients who require an admission to advert suicide, and b) patients whose suicidal thoughts 
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and behaviour might be related to a personality disorder or coping problems and who might 
benefit more from outpatient treatment. In the latter group, patients might be more amenable 
to interventions that foster individual autonomy. This finding is of high clinical and policy 
relevance as, until now, the general assumption in research has been that the interventions will 
work equally for both outcomes. It underscores the need to be able to discern risk for 
completed suicide from risk for attempted suicide in clinical practice. However, making such 
determinations remains a substantial clinical challenge. 
The findings also show that multilevel interventions are more effective than single 
level interventions and, further, that effect size rises significantly with the number of levels 
involved. Regarding synergism, a synergistic effect of multilevel interventions would ideally 
occur when the combined effect of the interventions is greater than the sum of the individual 
effects. This could be expressed as an exponential relationship between the numbers of 
intervention levels. In this study, a more linear relationship was found. However, as the effect 
sizes were considerable, ranging from -0.3 to -0.5 and -0.8 for the three-level intervention, a 
ceiling effect might have occurred. Although this does not yet provide direct evidence for 
synergism as described above, the findings are promising. In view of the low number of 
studies with more than one level, further research into multilevel interventions is 
recommended. Due to the added value of multilevel interventions and the synergistic 
potential, we recommend the implementation of multilevel suicide prevention interventions 
above one level. 
STRENGTHS AND LIMITATIONS
This study is the first to perform a systematic review and meta-analysis evaluating controlled 
studies examining the effect of any kind of suicide prevention intervention and providing an 
estimate of the effect size. The number of participants was high, 252,932, and the focus on 
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quantitative outcomes for completed and attempted suicides enabled us to establish clear 
outcomes of high societal relevance. Moreover, despite completed suicides being a very low 
base rate behavior, we found significant results which is probably due to the very large 
number of patients that were included in our study. There were no indications for publication 
bias, and it is not expected that relevant studies were excluded or missed in the review process 
since the authors consulted multiple sources for the identification of studies. With regard to 
limitations, we compared the three intervention conditions that were examined in the 
Wasserman et al. (2015) study43 separately, with the one control condition of their study for 
the meta-analysis, rather than comparing the three interventions together with the control 
condition. This was done to prevent the loss of relevant information, as there were differences 
in the interventions themselves and, importantly, also in their effectiveness in the prevention 
of suicide. A second limitation is that we only included two multilevel interventions in the 
meta-analysis of which one was a two-level intervention and one was a three-level 
intervention. Multilevel interventions should, therefore, be the focus of further research, as the 
current evidence indicates a greater effect of multilevel interventions compared to unilevel 
interventions and synergistic potential. Moreover, completed suicides remain a low base rate 
behavior. This resulted in our study in a less precise estimate of the effect, compared to 
suicide attempts. It is desirable for future research that more studies will examine the effect of 
suicide prevention interventions on preventing completed suicide, as more studies will enable 
more precise estimates of the effects.
FUTURE RESEARCH
Although the number of participants in this review was high (N=252,932), and the number 
included in the meta-analysis as well (N=29,071), the number of controlled studies reporting 
on completed or attempted suicides identified in this study (N=16) was lower than expected in 
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view of the globally rising suicide rates and the 2013 commitment of the World Health 
Organisation Member States for the development of suicide prevention interventions. Many 
studies are non-controlled investigations that report on indirect precursors of suicide such as 
suicidal ideation. This might be due to the fact that suicide is a statistically rare event; 
however, preventing suicide should be the ultimate goal of a suicide prevention intervention. 
We, therefore, recommend future research with controlled designs to further examine the 
effectiveness of suicide prevention interventions  especially multilevel interventions  on 
numbers of completed or attempted suicides. Future research should also examine further 
differential effects across outcomes and across specific characteristics of settings. For 
example, for some people, a psychiatric admission might be very effective in preventing 
suicidal behaviours, while for others it might cause pervasive distress.64 Also, some settings 
may have more effect on prevention of completed suicides, while others may be more 
effective for attempted suicides. More insight is needed into which characteristics contribute 
to making an intervention in a particular setting more or less effective, and in which respect. 
This study shows that the assumption that interventions have the same effect on completed 
and attempted suicides, and in different settings, is no longer valid. A related recommendation 
for future research would be to determine optimal strategies for professionals to discern risk 
for completed suicide from risk for an attempt, as appropriate interventions for each may 
differ. Finally, further research is needed to explore and further improve synergism in 
multilevel interventions.
CONCLUSION
Suicide prevention interventions are effective in preventing suicidal behavior and should be 
widely implemented. The findings suggest that clinicians should make an assessment of 
whether their patient is at serious risk for completing suicide. This will assist in determining 
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the most appropriate treatment: intervention provided in the psychiatric ward of a general 
hospital or, alternatively, prevention of attempted suicide in an outpatient specialty mental 
health clinic. Moreover, multilevel interventions should be the focus of further research due to 
a greater effect and synergistic potential. 
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Appendix 2: Search strategy
PubMed
#1 Systematic reviews
(suicide[MeSH Terms] OR suicide[All Fields]) AND (prevention and 
control[Subheading] OR (prevention[All Fields] AND control[All Fields]) OR 
prevention and control[All Fields] OR prevention[All Fields]) AND (methods[MeSH 
Terms] OR methods[All Fields] OR intervention[All Fields]) AND (review[Publication 
Type] OR review literature as topic[MeSH Terms] OR systematic review[All Fields]) 
AND (2011/01/01[PDAT] : 2017/12/15[PDAT])
#2 Clinical trials
(suicide[MeSH Terms] OR suicide[All Fields]) AND (prevention and 
control[Subheading] OR (prevention[All Fields] AND control[All Fields]) OR 
prevention and control[All Fields] OR prevention[All Fields]) AND (methods[MeSH 
Terms] OR methods[All Fields] OR intervention[All Fields]) AND (clinical 
trial[Publication Type] OR clinical trials as topic[MeSH Terms] OR clinical trial[All 
Fields]) AND (2011/01/01[PDAT] : 2017/12/15[PDAT])
The PubMed search strategy for systematic reviews and clinical trials was also translated for 
the PsycINFO and Cochrane databases. 
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